group_id,Component_1,apul,peve,ptua,type,avg_identity,query,accession,id,reviewed,protein_name,organism,pident,length,evalue,bitscore,title,go_ids,go_bp,go_cc,go_mf,goslim_ids,goslim_names
OG_03116,0.3907958070655482,FUN_012430-T1,Peve_00026925,Pocillopora_meandrina_HIv1___RNAseq.g23681.t1,three_way,55.942,FUN_012430-T1,Q7TXL8,,,,,25.4,2226.0,7.9e-140,501.5,sp|Q7TXL8|PPSC_MYCBO Phenolphthiocerol/phthiocerol polyketide synthase subunit C OS=Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97) OX=233413 GN=ppsC PE=1 SV=1,,,,,,
OG_02366,0.3561842607520677,FUN_008973-T1,Peve_00044338,Pocillopora_meandrina_HIv1___RNAseq.g3943.t1,three_way,66.187,FUN_008973-T1,P70057,,,,,37.0,573.0,1.5999999999999999e-83,312.4,sp|P70057|KCNQ1_XENLA Potassium voltage-gated channel subfamily KQT member 1 OS=Xenopus laevis OX=8355 GN=kcnq1 PE=1 SV=2,,,,,,
OG_01314,0.3490134111079002,FUN_005177-T1,Peve_00022720,Pocillopora_meandrina_HIv1___RNAseq.g7584.t1,three_way,78.689,FUN_005177-T1,Q7Z401,MYCPP_HUMAN,,C-myc promoter-binding protein (DENN domain-containing protein 4A),Homo sapiens (Human),34.8,1885.0,8.6e-282,971.8,sp|Q7Z401|MYCPP_HUMAN C-myc promoter-binding protein OS=Homo sapiens OX=9606 GN=DENND4A PE=1 SV=2,GO:0003677; GO:0005085; GO:0005634; GO:0005829; GO:0006355; GO:0031410; GO:0032483,regulation of DNA-templated transcription [GO:0006355]; regulation of Rab protein signal transduction [GO:0032483],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634],DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085],GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0031410; GO:0043226; GO:0098772,DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_08539,0.3477389986163733,FUN_037489-T1,Peve_00020410,Pocillopora_meandrina_HIv1___RNAseq.g1305.t1,three_way,76.29033333333334,FUN_037489-T1,A2VEI2,MICU1_DROME,,"Calcium uptake protein 1 homolog, mitochondrial (Mitochondrial calcium uptake 1)",Drosophila melanogaster (Fruit fly),53.7,376.0,1.5e-108,394.8,"sp|A2VEI2|MICU1_DROME Calcium uptake protein 1 homolog, mitochondrial OS=Drosophila melanogaster OX=7227 GN=MICU1 PE=2 SV=1",GO:0005509; GO:0005758; GO:0007615; GO:0036444; GO:0051560; GO:0051561; GO:0072375; GO:1990246,anesthesia-resistant memory [GO:0007615]; calcium import into the mitochondrion [GO:0036444]; medium-term memory [GO:0072375]; mitochondrial calcium ion homeostasis [GO:0051560]; positive regulation of mitochondrial calcium ion concentration [GO:0051561],mitochondrial intermembrane space [GO:0005758]; uniplex complex [GO:1990246],calcium ion binding [GO:0005509],GO:0050877; GO:0055085,nervous system process; transmembrane transport
OG_10186,0.3450448880674587,FUN_043601-T1,Peve_00040384,Pocillopora_meandrina_HIv1___RNAseq.g6949.t1,three_way,45.54,FUN_043601-T1,Q4LDE5,SVEP1_HUMAN,,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)",Homo sapiens (Human),28.0,1276.0,2.1e-133,478.8,"sp|Q4LDE5|SVEP1_HUMAN Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SVEP1 PE=1 SV=3",GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193,epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640],GO:0003013; GO:0005576; GO:0005615; GO:0005634; GO:0034330; GO:0043226; GO:0048856; GO:0098631,circulatory system process; extracellular region; extracellular space; nucleus; cell junction organization; organelle; anatomical structure development; cell adhesion mediator activity
OG_10180,0.3383952261887036,FUN_043593-T1,Peve_00010457,Pocillopora_meandrina_HIv1___RNAseq.g6971.t1,three_way,55.73066666666666,FUN_043593-T1,Q96PZ7,,,,,29.0,497.0,3.2e-52,208.4,sp|Q96PZ7|CSMD1_HUMAN CUB and sushi domain-containing protein 1 OS=Homo sapiens OX=9606 GN=CSMD1 PE=1 SV=3,,,,,,
OG_07037,0.3375788586610795,FUN_032232-T1,Peve_00043437,Pocillopora_meandrina_HIv1___RNAseq.g24836.t1,three_way,68.60266666666666,FUN_032232-T1,Q6DG22,ADA_DANRE,,Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase),Danio rerio (Zebrafish) (Brachydanio rerio),48.0,350.0,3.3e-91,336.7,sp|Q6DG22|ADA_DANRE Adenosine deaminase OS=Danio rerio OX=7955 GN=ada PE=2 SV=2,GO:0004000; GO:0005764; GO:0005829; GO:0006154; GO:0008270; GO:0009117; GO:0009168; GO:0009897; GO:0042110; GO:0043103; GO:0046103; GO:0046936; GO:0060169; GO:0060205; GO:0070161,adenosine catabolic process [GO:0006154]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; T cell activation [GO:0042110],anchoring junction [GO:0070161]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; lysosome [GO:0005764],2'-deoxyadenosine deaminase activity [GO:0046936]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005764; GO:0005773; GO:0005829; GO:0016787; GO:0043226; GO:0055086; GO:1901135,immune system process; catalytic activity; lysosome; vacuole; cytosol; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_08101,0.3352112716072911,FUN_035845-T1,Peve_00032505,Pocillopora_meandrina_HIv1___RNAseq.g11954.t1,three_way,74.447,FUN_035845-T1,A0JMQ0,,,,,61.0,623.0,8.5e-230,798.1,sp|A0JMQ0|BOP1_DANRE Ribosome biogenesis protein bop1 OS=Danio rerio OX=7955 GN=bop1 PE=2 SV=1,,,,,,
OG_04241,0.3324637264901867,FUN_017762-T1,Peve_00003285,Pocillopora_meandrina_HIv1___RNAseq.g441.t1,three_way,80.27833333333334,FUN_017762-T1,Q8BPM2,,,,,46.1,857.0,7.6e-203,708.8,sp|Q8BPM2|M4K5_MOUSE Mitogen-activated protein kinase kinase kinase kinase 5 OS=Mus musculus OX=10090 GN=Map4k5 PE=1 SV=2,,,,,,
OG_08928,0.3316425046973735,FUN_038386-T1,Peve_00000061,Pocillopora_meandrina_HIv1___RNAseq.g28288.t1,three_way,58.09316666666667,FUN_038386-T1,P16065,,,,,37.9,1080.0,5.1e-181,636.7,sp|P16065|GCY_STRPU Speract receptor OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_05881,0.3315664140962405,FUN_026034-T1,Peve_00022184,Pocillopora_meandrina_HIv1___RNAseq.g10547.t1,three_way,87.94766666666666,FUN_026034-T1,P29074,PTN4_HUMAN,,Tyrosine-protein phosphatase non-receptor type 4 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG1) (MEG) (PTPase-MEG1),Homo sapiens (Human),43.1,929.0,2e-217,757.3,sp|P29074|PTN4_HUMAN Tyrosine-protein phosphatase non-receptor type 4 OS=Homo sapiens OX=9606 GN=PTPN4 PE=1 SV=1,GO:0004725; GO:0004726; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006470; GO:0008092; GO:0009898; GO:0035254,protein dephosphorylation [GO:0006470],cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654],cytoskeletal protein binding [GO:0008092]; glutamate receptor binding [GO:0035254]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0005654; GO:0005829; GO:0005856; GO:0008092; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; cytosol; cytoskeleton; cytoskeletal protein binding; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_00053,0.323939141705178,FUN_000323-T1,Peve_00012596,Pocillopora_meandrina_HIv1___RNAseq.g29002.t2,three_way,82.90066666666667,FUN_000323-T1,Q9QYF3,MYO5A_RAT,,"Unconventional myosin-Va (Dilute myosin heavy chain, non-muscle)",Rattus norvegicus (Rat),51.1,1879.0,0.0,1338.6,sp|Q9QYF3|MYO5A_RAT Unconventional myosin-Va OS=Rattus norvegicus OX=10116 GN=Myo5a PE=1 SV=1,GO:0000146; GO:0000149; GO:0001726; GO:0001750; GO:0003774; GO:0003779; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005764; GO:0005769; GO:0005770; GO:0005777; GO:0005783; GO:0005790; GO:0005794; GO:0005829; GO:0005882; GO:0005884; GO:0006582; GO:0006887; GO:0006892; GO:0007015; GO:0007268; GO:0007601; GO:0008021; GO:0015629; GO:0016020; GO:0016192; GO:0016236; GO:0016459; GO:0016461; GO:0016887; GO:0017075; GO:0017157; GO:0019901; GO:0030048; GO:0030050; GO:0030073; GO:0030141; GO:0030318; GO:0030424; GO:0030425; GO:0031267; GO:0031982; GO:0031987; GO:0032252; GO:0032400; GO:0032402; GO:0032433; GO:0032593; GO:0032869; GO:0033602; GO:0042417; GO:0042438; GO:0042470; GO:0042476; GO:0042552; GO:0042641; GO:0042642; GO:0042759; GO:0042802; GO:0043008; GO:0043025; GO:0043473; GO:0044877; GO:0048066; GO:0048306; GO:0048820; GO:0050808; GO:0050885; GO:0051015; GO:0051643; GO:0051967; GO:0055037; GO:0065003; GO:0072659; GO:0097718; GO:0098685; GO:0098794; GO:0098871; GO:0098978; GO:0099089; GO:0099566; GO:0099640; GO:0150103; GO:1900078; GO:1903078; GO:1904754; GO:1990904,"actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; axo-dendritic protein transport [GO:0099640]; cellular response to insulin stimulus [GO:0032869]; chemical synaptic transmission [GO:0007268]; developmental pigmentation [GO:0048066]; dopamine metabolic process [GO:0042417]; endoplasmic reticulum localization [GO:0051643]; establishment of endoplasmic reticulum localization to postsynapse [GO:0099089]; exocytosis [GO:0006887]; hair follicle maturation [GO:0048820]; insulin secretion [GO:0030073]; locomotion involved in locomotory behavior [GO:0031987]; long-chain fatty acid biosynthetic process [GO:0042759]; macroautophagy [GO:0016236]; melanin biosynthetic process [GO:0042438]; melanin metabolic process [GO:0006582]; melanocyte differentiation [GO:0030318]; melanosome localization [GO:0032400]; melanosome transport [GO:0032402]; myelination [GO:0042552]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuromuscular process controlling balance [GO:0050885]; odontogenesis [GO:0042476]; pigmentation [GO:0043473]; positive regulation of cellular response to insulin stimulus [GO:1900078]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; protein-containing complex assembly [GO:0065003]; reactive gliosis [GO:0150103]; regulation of exocytosis [GO:0017157]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; secretory granule localization [GO:0032252]; synapse organization [GO:0050808]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601]","actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actomyosin [GO:0042641]; actomyosin, myosin complex part [GO:0042642]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; intermediate filament [GO:0005882]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; myosin complex [GO:0016459]; neuronal cell body [GO:0043025]; peroxisome [GO:0005777]; photoreceptor outer segment [GO:0001750]; postsynapse [GO:0098794]; postsynaptic actin cytoskeleton [GO:0098871]; recycling endosome [GO:0055037]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule [GO:0030141]; smooth endoplasmic reticulum [GO:0005790]; synaptic vesicle [GO:0008021]; unconventional myosin complex [GO:0016461]; vesicle [GO:0031982]",actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein binding [GO:0043008]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075],GO:0003774; GO:0003824; GO:0005764; GO:0005768; GO:0005773; GO:0005777; GO:0005783; GO:0005794; GO:0005829; GO:0005856; GO:0006629; GO:0006886; GO:0006914; GO:0006954; GO:0007018; GO:0008092; GO:0016192; GO:0016787; GO:0016853; GO:0023052; GO:0030154; GO:0031410; GO:0034330; GO:0043226; GO:0050877; GO:0065003; GO:0072659; GO:0140657,cytoskeletal motor activity; catalytic activity; lysosome; endosome; vacuole; peroxisome; endoplasmic reticulum; Golgi apparatus; cytosol; cytoskeleton; lipid metabolic process; intracellular protein transport; autophagy; inflammatory response; microtubule-based movement; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; isomerase activity; signaling; cell differentiation; cytoplasmic vesicle; cell junction organization; organelle; nervous system process; protein-containing complex assembly; protein localization to plasma membrane; ATP-dependent activity
OG_06060,0.3230527342285553,FUN_026826-T1,Peve_00021661,Pocillopora_meandrina_HIv1___RNAseq.g2905.t1,three_way,81.5875,FUN_026826-T1,Q6PHS6,,,,,41.4,950.0,6.9e-205,715.7,sp|Q6PHS6|SNX13_MOUSE Sorting nexin-13 OS=Mus musculus OX=10090 GN=Snx13 PE=2 SV=1,,,,,,
OG_09889,0.3214102392731228,FUN_042965-T1,Peve_00039044,Pocillopora_meandrina_HIv1___RNAseq.g7111.t1,three_way,59.85383333333333,FUN_042965-T1,Q80ZJ6,,,,,34.8,771.0,3.4e-101,370.9,sp|Q80ZJ6|ZER1_MOUSE Protein zer-1 homolog OS=Mus musculus OX=10090 GN=Zer1 PE=1 SV=1,,,,,,
OG_09806,0.3178983597303076,FUN_042624-T1,Peve_00016197,Pocillopora_meandrina_HIv1___RNAseq.g11511.t1,three_way,48.837833333333336,FUN_042624-T1,E9Q414,APOB_MOUSE,,Apolipoprotein B-100 (Apo B-100) [Cleaved into: Apolipoprotein B-48 (Apo B-48)],Mus musculus (Mouse),24.7,1102.0,3e-65,254.6,sp|E9Q414|APOB_MOUSE Apolipoprotein B-100 OS=Mus musculus OX=10090 GN=Apob PE=1 SV=1,GO:0001701; GO:0005543; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0006642; GO:0007283; GO:0007399; GO:0008201; GO:0008203; GO:0009566; GO:0009615; GO:0009791; GO:0010628; GO:0010744; GO:0010886; GO:0016042; GO:0019433; GO:0030301; GO:0030317; GO:0033344; GO:0034359; GO:0034361; GO:0034362; GO:0034363; GO:0034374; GO:0034383; GO:0035473; GO:0042157; GO:0042158; GO:0042159; GO:0042632; GO:0042953; GO:0043025; GO:0045540; GO:0048018; GO:0048844; GO:0050750; GO:0051649; GO:0070971; GO:0071402; GO:0120020,artery morphogenesis [GO:0048844]; cellular response to lipoprotein particle stimulus [GO:0071402]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; establishment of localization in cell [GO:0051649]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; regulation of cholesterol biosynthetic process [GO:0045540]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; extracellular region [GO:0005576]; intermediate-density lipoprotein particle [GO:0034363]; lipid droplet [GO:0005811]; low-density lipoprotein particle [GO:0034362]; mature chylomicron [GO:0034359]; neuronal cell body [GO:0043025]; very-low-density lipoprotein particle [GO:0034361],cholesterol transfer activity [GO:0120020]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; phospholipid binding [GO:0005543]; receptor ligand activity [GO:0048018],GO:0005215; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0007018; GO:0008289; GO:0022414; GO:0030163; GO:0043226; GO:0048018; GO:0048856; GO:0048870; GO:0098772,transporter activity; extracellular region; endoplasmic reticulum; lipid droplet; cytosol; lipid metabolic process; microtubule-based movement; lipid binding; reproductive process; protein catabolic process; organelle; receptor ligand activity; anatomical structure development; cell motility; molecular function regulator activity
OG_06273,0.3138693201374324,FUN_028309-T1,Peve_00037726,Pocillopora_meandrina_HIv1___RNAseq.g16424.t1,three_way,73.845,FUN_028309-T1,O15550,KDM6A_HUMAN,,Lysine-specific demethylase 6A (EC 1.14.11.68) (Histone demethylase UTX) (Ubiquitously-transcribed TPR protein on the X chromosome) (Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase 6A),Homo sapiens (Human),40.4,1012.0,2.5e-115,418.3,sp|O15550|KDM6A_HUMAN Lysine-specific demethylase 6A OS=Homo sapiens OX=9606 GN=KDM6A PE=1 SV=2,GO:0000978; GO:0005634; GO:0005654; GO:0006338; GO:0007507; GO:0010468; GO:0031490; GO:0032452; GO:0035097; GO:0044666; GO:0046872; GO:0071558,chromatin remodeling [GO:0006338]; heart development [GO:0007507]; regulation of gene expression [GO:0010468],histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin DNA binding [GO:0031490]; histone demethylase activity [GO:0032452]; histone H3K27me2/H3K27me3 demethylase activity [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0016491; GO:0043226; GO:0048856; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromatin organization; oxidoreductase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_05951,0.3102043744960032,FUN_026211-T1,Peve_00044665,Pocillopora_meandrina_HIv1___RNAseq.g3049.t1,three_way,49.01616666666666,FUN_026211-T1,A2AX52,CO6A4_MOUSE,,Collagen alpha-4(VI) chain,Mus musculus (Mouse),24.8,1256.0,9.1e-63,246.1,sp|A2AX52|CO6A4_MOUSE Collagen alpha-4(VI) chain OS=Mus musculus OX=10090 GN=Col6a4 PE=1 SV=2,GO:0005518; GO:0005576; GO:0005589; GO:0007155; GO:0030198; GO:0031012; GO:0032991; GO:0062023,cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198],collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991],collagen binding [GO:0005518],GO:0005576; GO:0007155; GO:0030198; GO:0030312; GO:0031012,extracellular region; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_07665,0.3092920251276871,FUN_034720-T1,Peve_00033269,Pocillopora_meandrina_HIv1___RNAseq.g28723.t1,three_way,62.28366666666667,FUN_034720-T1,P82094,TMF1_HUMAN,,TATA element modulatory factor (TMF) (Androgen receptor coactivator 160 kDa protein) (Androgen receptor-associated protein of 160 kDa),Homo sapiens (Human),40.1,685.0,2.8999999999999997e-43,179.1,sp|P82094|TMF1_HUMAN TATA element modulatory factor OS=Homo sapiens OX=9606 GN=TMF1 PE=1 SV=2,GO:0000139; GO:0001675; GO:0001819; GO:0003677; GO:0003713; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0007289; GO:0010629; GO:0030317; GO:0030521; GO:0032275; GO:0033327; GO:0042742; GO:0045944; GO:0050681; GO:0061136; GO:1904019; GO:1904036; GO:2000845,acrosome assembly [GO:0001675]; androgen receptor signaling pathway [GO:0030521]; defense response to bacterium [GO:0042742]; epithelial cell apoptotic process [GO:1904019]; flagellated sperm motility [GO:0030317]; Leydig cell differentiation [GO:0033327]; luteinizing hormone secretion [GO:0032275]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of gene expression [GO:0010629]; positive regulation of cytokine production [GO:0001819]; positive regulation of testosterone secretion [GO:2000845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of proteasomal protein catabolic process [GO:0061136]; spermatid nucleus differentiation [GO:0007289],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634],DNA binding [GO:0003677]; nuclear androgen receptor binding [GO:0050681]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0006355; GO:0007018; GO:0012501; GO:0022414; GO:0030154; GO:0043226; GO:0048870; GO:0060090; GO:0140110,DNA binding; nucleus; endoplasmic reticulum; Golgi apparatus; cytosol; regulation of DNA-templated transcription; microtubule-based movement; programmed cell death; reproductive process; cell differentiation; organelle; cell motility; molecular adaptor activity; transcription regulator activity
OG_00386,0.3091139603761237,FUN_001238-T1,Peve_00002842,Pocillopora_meandrina_HIv1___RNAseq.g2515.t2,three_way,45.375,FUN_001238-T1,Q8IVU1,,,,,32.5,517.0,1.1e-67,260.4,sp|Q8IVU1|IGDC3_HUMAN Immunoglobulin superfamily DCC subclass member 3 OS=Homo sapiens OX=9606 GN=IGDCC3 PE=1 SV=2,,,,,,
OG_09673,0.3078075320766861,FUN_041895-T1,Peve_00026172,Pocillopora_meandrina_HIv1___RNAseq.g15351.t1,three_way,68.37666666666668,FUN_041895-T1,Q505H7,,,,,49.0,392.0,1.3e-80,302.4,sp|Q505H7|IWS1_XENTR Protein IWS1 homolog OS=Xenopus tropicalis OX=8364 GN=iws1 PE=2 SV=1,,,,,,
OG_06110,0.3071182594013327,FUN_027815-T1,Peve_00036487,Pocillopora_meandrina_HIv1___RNAseq.g13889.t2,three_way,90.976,FUN_027815-T1,Q23356,MIG15_CAEEL,,Serine/threonine-protein kinase mig-15 (EC 2.7.11.1) (Abnormal cell migration protein 15),Caenorhabditis elegans,44.9,1094.0,1.7e-240,833.9,sp|Q23356|MIG15_CAEEL Serine/threonine-protein kinase mig-15 OS=Caenorhabditis elegans OX=6239 GN=mig-15 PE=2 SV=3,GO:0000165; GO:0002119; GO:0004674; GO:0005524; GO:0005737; GO:0010171; GO:0022414; GO:0030334; GO:0032228; GO:0033563; GO:0043408; GO:0048812; GO:0106310,"body morphogenesis [GO:0010171]; dorsal/ventral axon guidance [GO:0033563]; MAPK cascade [GO:0000165]; nematode larval development [GO:0002119]; neuron projection morphogenesis [GO:0048812]; regulation of cell migration [GO:0030334]; regulation of MAPK cascade [GO:0043408]; regulation of synaptic transmission, GABAergic [GO:0032228]; reproductive process [GO:0022414]",cytoplasm [GO:0005737],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0022414; GO:0048856; GO:0140096,"catalytic activity; transferase activity; reproductive process; anatomical structure development; catalytic activity, acting on a protein"
OG_01466,0.3064463734717321,FUN_006002-T1,Peve_00036060,Pocillopora_meandrina_HIv1___RNAseq.g19927.t1,three_way,76.86133333333333,FUN_006002-T1,A0A1U8QWA2,ATR12_EMENI,,Glycine betaine reductase ATRR (Nonribosomal peptide synthetase-like protein ATRR) [Includes: Carboxylic acid reductase (EC 1.2.1.-); Aldehyde reductase (EC 1.1.1.-)],Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) (Aspergillus nidulans),38.2,1317.0,3.3e-237,823.5,sp|A0A1U8QWA2|ATR12_EMENI Glycine betaine reductase ATRR OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) OX=227321 GN=ATRR PE=1 SV=1,GO:0009058; GO:0016491; GO:0031177,biosynthetic process [GO:0009058],,oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177],GO:0003824; GO:0016491,catalytic activity; oxidoreductase activity
OG_01156,0.3059581963736363,FUN_004767-T1,Peve_00007781,Pocillopora_meandrina_HIv1___RNAseq.g6697.t1,three_way,76.52799999999999,FUN_004767-T1,O57457,,,,,44.1,474.0,3.5e-96,354.4,sp|O57457|E41LA_DANRE Band 4.1-like protein 4 OS=Danio rerio OX=7955 GN=epb41l4a PE=2 SV=1,,,,,,
OG_01747,0.3051106292488093,FUN_007073-T1,Peve_00019897,Pocillopora_meandrina_HIv1___RNAseq.g20081.t1,three_way,71.9425,FUN_007073-T1,Q9DER7,,,,,47.7,870.0,3e-256,886.3,sp|Q9DER7|TLL1_CHICK Tolloid-like protein 1 OS=Gallus gallus OX=9031 GN=TLL1 PE=2 SV=1,,,,,,
OG_07716,0.3042038596989,FUN_034870-T1,Peve_00005769,Pocillopora_meandrina_HIv1___RNAseq.g27159.t1,three_way,54.551,FUN_034870-T1,Q91Y77,,,,,29.8,423.0,2.3e-49,198.7,sp|Q91Y77|MOT10_RAT Monocarboxylate transporter 10 OS=Rattus norvegicus OX=10116 GN=Slc16a10 PE=1 SV=2,,,,,,
OG_05007,0.3038429072402974,FUN_023157-T1,Peve_00017447,Pocillopora_meandrina_HIv1___RNAseq.g12682.t1,three_way,76.46433333333333,FUN_023157-T1,A7YWP4,HUTH_BOVIN,,Histidine ammonia-lyase (Histidase) (EC 4.3.1.3),Bos taurus (Bovine),62.6,642.0,4.4e-222,772.3,sp|A7YWP4|HUTH_BOVIN Histidine ammonia-lyase OS=Bos taurus OX=9913 GN=HAL PE=2 SV=1,GO:0004397; GO:0005737; GO:0006548; GO:0019556; GO:0019557,L-histidine catabolic process [GO:0006548]; L-histidine catabolic process to glutamate and formamide [GO:0019556]; L-histidine catabolic process to glutamate and formate [GO:0019557],cytoplasm [GO:0005737],histidine ammonia-lyase activity [GO:0004397],GO:0003824; GO:0006520; GO:0016829,catalytic activity; amino acid metabolic process; lyase activity
OG_06089,0.303267573914621,FUN_027127-T1,Peve_00039622,Pocillopora_meandrina_HIv1___RNAseq.g15332.t1,three_way,58.584833333333336,FUN_027127-T1,Q8K245,UVRAG_MOUSE,,UV radiation resistance-associated protein,Mus musculus (Mouse),43.1,450.0,5.2e-84,313.9,sp|Q8K245|UVRAG_MOUSE UV radiation resistance-associated protein OS=Mus musculus OX=10090 GN=Uvrag PE=1 SV=2,GO:0000149; GO:0000421; GO:0000775; GO:0005764; GO:0005769; GO:0005770; GO:0005783; GO:0005813; GO:0006281; GO:0006890; GO:0007051; GO:0007059; GO:0007098; GO:0010506; GO:0017124; GO:0030496; GO:0032465; GO:0032801; GO:0032991; GO:0035032; GO:0035493; GO:0036092; GO:0045335; GO:0046718; GO:0051684; GO:0070418; GO:0097352; GO:0097680,"autophagosome maturation [GO:0097352]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; maintenance of Golgi location [GO:0051684]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; receptor catabolic process [GO:0032801]; regulation of autophagy [GO:0010506]; regulation of cytokinesis [GO:0032465]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; SNARE complex assembly [GO:0035493]; spindle organization [GO:0007051]; symbiont entry into host cell [GO:0046718]","autophagosome membrane [GO:0000421]; centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; DNA-dependent protein kinase complex [GO:0070418]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; late endosome [GO:0005770]; lysosome [GO:0005764]; midbody [GO:0030496]; phagocytic vesicle [GO:0045335]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; protein-containing complex [GO:0032991]",SH3 domain binding [GO:0017124]; SNARE binding [GO:0000149],GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005815; GO:0006281; GO:0006629; GO:0007010; GO:0007059; GO:0016192; GO:0031410; GO:0043226; GO:0065003,lysosome; endosome; vacuole; endoplasmic reticulum; microtubule organizing center; DNA repair; lipid metabolic process; cytoskeleton organization; chromosome segregation; vesicle-mediated transport; cytoplasmic vesicle; organelle; protein-containing complex assembly
OG_09609,0.3031656659794645,FUN_041767-T1,Peve_00041572,Pocillopora_meandrina_HIv1___RNAseq.g15244.t1,three_way,57.924,FUN_041767-T1,Q6WRH9,,,,,29.6,406.0,5.6000000000000005e-28,128.6,sp|Q6WRH9|IGS10_RAT Immunoglobulin superfamily member 10 OS=Rattus norvegicus OX=10116 GN=Igsf10 PE=1 SV=1,,,,,,
OG_09760,0.3028393449681136,FUN_042034-T1,Peve_00035625,Pocillopora_meandrina_HIv1___RNAseq.g15181.t1,three_way,72.15583333333333,FUN_042034-T1,Q8C0W1,,,,,27.5,840.0,4.6e-70,268.1,sp|Q8C0W1|ANMY1_MOUSE Ankyrin repeat and MYND domain-containing protein 1 OS=Mus musculus OX=10090 GN=Ankmy1 PE=1 SV=1,,,,,,
OG_06527,0.301600583904882,FUN_029356-T1,Peve_00023383,Pocillopora_meandrina_HIv1___RNAseq.g17292.t1,three_way,73.16533333333334,FUN_029356-T1,Q15397,,,,,44.1,424.0,5.2e-92,339.7,sp|Q15397|PUM3_HUMAN Pumilio homolog 3 OS=Homo sapiens OX=9606 GN=PUM3 PE=1 SV=3,,,,,,
OG_07824,0.3010169095517114,FUN_035094-T1,Peve_00014774,Pocillopora_meandrina_HIv1___RNAseq.g27699.t1,three_way,62.495,FUN_035094-T1,Q92896,GSLG1_HUMAN,,Golgi apparatus protein 1 (CFR-1) (Cysteine-rich fibroblast growth factor receptor) (E-selectin ligand 1) (ESL-1) (Golgi sialoglycoprotein MG-160),Homo sapiens (Human),40.9,1085.0,6.199999999999999e-251,869.0,sp|Q92896|GSLG1_HUMAN Golgi apparatus protein 1 OS=Homo sapiens OX=9606 GN=GLG1 PE=1 SV=2,GO:0000139; GO:0005102; GO:0005794; GO:0005815; GO:0005886; GO:0007179; GO:0010955; GO:0016020; GO:0016485; GO:0017134; GO:0030512; GO:0031012; GO:0032330; GO:0060349; GO:0070062,bone morphogenesis [GO:0060349]; negative regulation of protein processing [GO:0010955]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein processing [GO:0016485]; regulation of chondrocyte differentiation [GO:0032330]; transforming growth factor beta receptor signaling pathway [GO:0007179],extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886],fibroblast growth factor binding [GO:0017134]; signaling receptor binding [GO:0005102],GO:0005794; GO:0005815; GO:0005886; GO:0030312; GO:0031012; GO:0043226; GO:0051604,Golgi apparatus; microtubule organizing center; plasma membrane; external encapsulating structure; extracellular matrix; organelle; protein maturation
OG_04250,0.30030289580829,FUN_017780-T1,Peve_00029909,Pocillopora_meandrina_HIv1___RNAseq.g9514.t1,three_way,48.56066666666667,,,,,,,,,,,,,,,,,
OG_08313,0.2996696517273994,FUN_036513-T1,Peve_00031408,Pocillopora_meandrina_HIv1___RNAseq.g27052.t1,three_way,58.79833333333333,FUN_036513-T1,A0A8I3PDQ1,CASL_CANLF,,Enhancer of filamentation 1 (CRK-associated substrate-related protein) (CAS-L) (Neural precursor cell expressed developmentally down-regulated protein 9) (NEDD-9) (p105),Canis lupus familiaris (Dog) (Canis familiaris),22.2,968.0,2.6e-26,122.5,sp|A0A8I3PDQ1|CASL_CANLF Enhancer of filamentation 1 OS=Canis lupus familiaris OX=9615 GN=NEDD9 PE=1 SV=1,GO:0000922; GO:0001772; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005925; GO:0005938; GO:0007155; GO:0007169; GO:0007611; GO:0016323; GO:0016477; GO:0030027; GO:0030336; GO:0032956; GO:0036064; GO:0045672; GO:0051301; GO:0061523; GO:0072686; GO:0097021; GO:0140131; GO:1900026; GO:1902952; GO:1903829; GO:1990782; GO:2000522,cell adhesion [GO:0007155]; cell division [GO:0051301]; cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cilium disassembly [GO:0061523]; learning or memory [GO:0007611]; lymphocyte migration into lymphoid organs [GO:0097021]; negative regulation of cell migration [GO:0030336]; positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of immunological synapse formation [GO:2000522]; positive regulation of lymphocyte chemotaxis [GO:0140131]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein localization [GO:1903829]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of actin cytoskeleton organization [GO:0032956],basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922],protein tyrosine kinase binding [GO:1990782],GO:0002376; GO:0005654; GO:0005794; GO:0005815; GO:0005829; GO:0007155; GO:0043226; GO:0044782; GO:0048870; GO:0050877,immune system process; nucleoplasm; Golgi apparatus; microtubule organizing center; cytosol; cell adhesion; organelle; cilium organization; cell motility; nervous system process
OG_01177,0.2981422933775177,FUN_004816-T1,Peve_00023831,Pocillopora_meandrina_HIv1___RNAseq.g8574.t1,three_way,59.54533333333333,FUN_004816-T1,Q25490,,,,,22.5,1034.0,1.1999999999999999e-35,155.2,sp|Q25490|APLP_MANSE Apolipophorins OS=Manduca sexta OX=7130 PE=2 SV=1,,,,,,
OG_08623,0.2964332994761794,FUN_037778-T1,Peve_00040702,Pocillopora_meandrina_HIv1___RNAseq.g1514.t1,three_way,68.98816666666667,,,,,,,,,,,,,,,,,
OG_01991,0.2963954303692454,FUN_008099-T1,Peve_00038883,Pocillopora_meandrina_HIv1___RNAseq.g30140.t1,three_way,82.39933333333333,FUN_008099-T1,O94806,KPCD3_HUMAN,,Serine/threonine-protein kinase D3 (EC 2.7.11.13) (Protein kinase C nu type) (Protein kinase EPK2) (nPKC-nu),Homo sapiens (Human),56.9,822.0,2.4e-263,909.8,sp|O94806|KPCD3_HUMAN Serine/threonine-protein kinase D3 OS=Homo sapiens OX=9606 GN=PRKD3 PE=1 SV=1,GO:0004674; GO:0004697; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0006468; GO:0007200; GO:0008270; GO:0016301; GO:0030148; GO:0035556; GO:0036064; GO:0106310,intracellular signal transduction [GO:0035556]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148],ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005815; GO:0005829; GO:0005886; GO:0006629; GO:0016740; GO:0140096,"catalytic activity; nucleoplasm; microtubule organizing center; cytosol; plasma membrane; lipid metabolic process; transferase activity; catalytic activity, acting on a protein"
OG_08874,0.2951205810021651,FUN_038271-T1,Peve_00010406,Pocillopora_meandrina_HIv1___RNAseq.g28323.t1,three_way,64.48483333333333,FUN_038271-T1,Q7TN88,,,,,29.4,1654.0,3.4e-170,602.1,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_04109,0.2950780110544274,FUN_016475-T1,Peve_00040144,Pocillopora_meandrina_HIv1___RNAseq.g10194.t1,three_way,66.4755,FUN_016475-T1,P0C5Y8,ALS2_RAT,,Alsin (Amyotrophic lateral sclerosis 2 protein homolog),Rattus norvegicus (Rat),30.6,1765.0,3.8e-188,661.0,sp|P0C5Y8|ALS2_RAT Alsin OS=Rattus norvegicus OX=10116 GN=Als2 PE=1 SV=1,GO:0001662; GO:0001701; GO:0001726; GO:0001881; GO:0005085; GO:0005096; GO:0005634; GO:0005737; GO:0005769; GO:0005813; GO:0005829; GO:0006979; GO:0007041; GO:0007409; GO:0007528; GO:0007626; GO:0008104; GO:0014069; GO:0016020; GO:0016050; GO:0016197; GO:0016601; GO:0030027; GO:0030424; GO:0030425; GO:0030426; GO:0031267; GO:0031982; GO:0032991; GO:0035249; GO:0042802; GO:0042803; GO:0043025; GO:0043197; GO:0043231; GO:0043539; GO:0043547; GO:0045860; GO:0048812; GO:0051036; GO:0051260; GO:0098978; GO:0099072,"axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; endosomal transport [GO:0016197]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; lysosomal transport [GO:0007041]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; protein homooligomerization [GO:0051260]; protein localization [GO:0008104]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]; vesicle organization [GO:0016050]",axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982],GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; small GTPase binding [GO:0031267],GO:0005634; GO:0005768; GO:0005815; GO:0005829; GO:0016192; GO:0023052; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0065003; GO:0098772,nucleus; endosome; microtubule organizing center; cytosol; vesicle-mediated transport; signaling; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity
OG_02202,0.2942715089914312,FUN_008577-T1,Peve_00028423,Pocillopora_meandrina_HIv1___RNAseq.g12779.t1,three_way,77.05433333333333,FUN_008577-T1,Q80Y56,,,,,37.4,505.0,3.3e-76,287.3,sp|Q80Y56|RBNS5_MOUSE Rabenosyn-5 OS=Mus musculus OX=10090 GN=Rbsn PE=1 SV=1,,,,,,
OG_06717,0.2942708195273608,FUN_031467-T1,Peve_00026558,Pocillopora_meandrina_HIv1___RNAseq.g5084.t2,three_way,78.09566666666667,FUN_031467-T1,Q5RDQ2,PALS1_PONAB,,Protein PALS1 (MAGUK p55 subfamily member 5) (Protein associated with Lin-7 1),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),46.4,576.0,2.3e-140,501.5,sp|Q5RDQ2|PALS1_PONAB Protein PALS1 OS=Pongo abelii OX=9601 GN=PALS1 PE=2 SV=1,GO:0005524; GO:0005794; GO:0005912; GO:0005923; GO:0016324; GO:0017015; GO:0021954; GO:0021987; GO:0030424; GO:0043204,central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015],adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; bicellular tight junction [GO:0005923]; Golgi apparatus [GO:0005794]; perikaryon [GO:0043204],ATP binding [GO:0005524],GO:0005794; GO:0043226; GO:0048856,Golgi apparatus; organelle; anatomical structure development
OG_01641,0.2940901773962172,FUN_006778-T1,Peve_00042981,Pocillopora_meandrina_HIv1___TS.g29885.t1,three_way,45.0235,FUN_006778-T1,P16092,FGFR1_MOUSE,,Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (MFR) (Proto-oncogene c-Fgr) (CD antigen CD331),Mus musculus (Mouse),33.7,784.0,2.6e-100,368.6,sp|P16092|FGFR1_MOUSE Fibroblast growth factor receptor 1 OS=Mus musculus OX=10090 GN=Fgfr1 PE=1 SV=2,GO:0000122; GO:0001525; GO:0001657; GO:0001701; GO:0001759; GO:0001837; GO:0002053; GO:0002062; GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007420; GO:0007435; GO:0007605; GO:0008201; GO:0008283; GO:0008284; GO:0008543; GO:0010463; GO:0010467; GO:0010468; GO:0010629; GO:0010966; GO:0010976; GO:0017134; GO:0021769; GO:0021847; GO:0030031; GO:0030324; GO:0030326; GO:0030901; GO:0031175; GO:0031410; GO:0035607; GO:0042169; GO:0042472; GO:0042473; GO:0042474; GO:0042803; GO:0043235; GO:0043536; GO:0043583; GO:0045666; GO:0045787; GO:0046777; GO:0048339; GO:0048378; GO:0048469; GO:0048514; GO:0048699; GO:0048762; GO:0048863; GO:0050678; GO:0051174; GO:0051897; GO:0055074; GO:0060038; GO:0060045; GO:0060117; GO:0060445; GO:0060484; GO:0060665; GO:0060979; GO:0070640; GO:0071344; GO:0071529; GO:0072089; GO:0090080; GO:0090272; GO:0090722; GO:0098794; GO:0098978; GO:0099151; GO:1903465; GO:1904383; GO:1905564; GO:2000648; GO:2000830; GO:2001028; GO:2001239,angiogenesis [GO:0001525]; auditory receptor cell development [GO:0060117]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium ion homeostasis [GO:0055074]; cardiac muscle cell proliferation [GO:0060038]; cell maturation [GO:0048469]; cell population proliferation [GO:0008283]; cell projection assembly [GO:0030031]; cementum mineralization [GO:0071529]; chondrocyte differentiation [GO:0002062]; diphosphate metabolic process [GO:0071344]; ear development [GO:0043583]; embryonic limb morphogenesis [GO:0030326]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; gene expression [GO:0010467]; generation of neurons [GO:0048699]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lung development [GO:0030324]; lung-associated mesenchyme development [GO:0060484]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell proliferation [GO:0010463]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron projection development [GO:0031175]; orbitofrontal cortex development [GO:0021769]; organ induction [GO:0001759]; outer ear morphogenesis [GO:0042473]; paraxial mesoderm development [GO:0048339]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic cell cycle DNA replication [GO:1903465]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of epithelial cell proliferation [GO:0050678]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; regulation of gene expression [GO:0010468]; regulation of lateral mesodermal cell fate specification [GO:0048378]; regulation of phosphate transport [GO:0010966]; regulation of phosphorus metabolic process [GO:0051174]; regulation of postsynaptic density assembly [GO:0099151]; response to sodium phosphate [GO:1904383]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; ureteric bud development [GO:0001657]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; ventricular zone neuroblast division [GO:0021847]; vitamin D3 metabolic process [GO:0070640],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; receptor complex [GO:0043235],ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201]; protein homodimerization activity [GO:0042803]; receptor-receptor interaction [GO:0090722]; SH2 domain binding [GO:0042169],GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0006355; GO:0006629; GO:0016740; GO:0023052; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0060089; GO:0140096,"catalytic activity; nucleus; cytosol; plasma membrane; regulation of DNA-templated transcription; lipid metabolic process; transferase activity; signaling; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; molecular transducer activity; catalytic activity, acting on a protein"
OG_08722,0.2940494620237054,FUN_037975-T1,Peve_00013890,Pocillopora_meandrina_HIv1___RNAseq.g26184.t1,three_way,52.15416666666667,FUN_037975-T1,Q8IY33,MILK2_HUMAN,,MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2),Homo sapiens (Human),36.1,280.0,6.1e-42,174.9,sp|Q8IY33|MILK2_HUMAN MICAL-like protein 2 OS=Homo sapiens OX=9606 GN=MICALL2 PE=1 SV=1,GO:0001725; GO:0005886; GO:0005911; GO:0005923; GO:0030036; GO:0030041; GO:0031005; GO:0031175; GO:0031267; GO:0032456; GO:0032482; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830; GO:0097750; GO:1903955,actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; endosome membrane tubulation [GO:0097750]; neuron projection development [GO:0031175]; positive regulation of protein targeting to mitochondrion [GO:1903955]; Rab protein signal transduction [GO:0032482]; substrate adhesion-dependent cell spreading [GO:0034446],bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stress fiber [GO:0001725],actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267],GO:0005768; GO:0005886; GO:0007010; GO:0007155; GO:0008092; GO:0016192; GO:0031410; GO:0034330; GO:0043226; GO:0061024; GO:0065003,endosome; plasma membrane; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; vesicle-mediated transport; cytoplasmic vesicle; cell junction organization; organelle; membrane organization; protein-containing complex assembly
OG_08722,0.2940494620237054,FUN_037975-T1,Peve_00013890,Pocillopora_meandrina_HIv1___RNAseq.g26184.t1,three_way,52.15416666666667,FUN_037975-T1,Q8IY33,MILK2_HUMAN,,MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2),Homo sapiens (Human),43.2,148.0,5.4e-22,108.6,sp|Q8IY33|MILK2_HUMAN MICAL-like protein 2 OS=Homo sapiens OX=9606 GN=MICALL2 PE=1 SV=1,GO:0001725; GO:0005886; GO:0005911; GO:0005923; GO:0030036; GO:0030041; GO:0031005; GO:0031175; GO:0031267; GO:0032456; GO:0032482; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830; GO:0097750; GO:1903955,actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; endosome membrane tubulation [GO:0097750]; neuron projection development [GO:0031175]; positive regulation of protein targeting to mitochondrion [GO:1903955]; Rab protein signal transduction [GO:0032482]; substrate adhesion-dependent cell spreading [GO:0034446],bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stress fiber [GO:0001725],actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267],GO:0005768; GO:0005886; GO:0007010; GO:0007155; GO:0008092; GO:0016192; GO:0031410; GO:0034330; GO:0043226; GO:0061024; GO:0065003,endosome; plasma membrane; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; vesicle-mediated transport; cytoplasmic vesicle; cell junction organization; organelle; membrane organization; protein-containing complex assembly
OG_00527,0.2936446866369367,FUN_001531-T1,Peve_00000632,Pocillopora_meandrina_HIv1___RNAseq.g2047.t1,three_way,79.239,FUN_001531-T1,A2RSQ0,,,,,43.6,1377.0,1.4e-312,1074.7,sp|A2RSQ0|DEN5B_MOUSE DENN domain-containing protein 5B OS=Mus musculus OX=10090 GN=Dennd5b PE=1 SV=2,,,,,,
OG_09346,0.2929023540501533,FUN_040329-T1,Peve_00014960,Pocillopora_meandrina_HIv1___TS.g20804.t1,three_way,59.10066666666667,FUN_040329-T1,Q96JI7,SPTCS_HUMAN,,Spatacsin (Colorectal carcinoma-associated protein) (Spastic paraplegia 11 protein),Homo sapiens (Human),27.8,1418.0,1.1e-133,480.3,sp|Q96JI7|SPTCS_HUMAN Spatacsin OS=Homo sapiens OX=9606 GN=SPG11 PE=1 SV=3,GO:0005730; GO:0005737; GO:0005765; GO:0005783; GO:0005829; GO:0005886; GO:0006606; GO:0007040; GO:0007268; GO:0007409; GO:0007528; GO:0007613; GO:0008088; GO:0019901; GO:0021957; GO:0030163; GO:0030424; GO:0030425; GO:0031410; GO:0033344; GO:0045202; GO:0047496; GO:0048489; GO:0048675; GO:0048741; GO:0051668; GO:0061744; GO:0090389; GO:0090659; GO:0097049; GO:1905037; GO:2001256,autophagosome organization [GO:1905037]; axo-dendritic transport [GO:0008088]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; chemical synaptic transmission [GO:0007268]; cholesterol efflux [GO:0033344]; corticospinal tract morphogenesis [GO:0021957]; localization within membrane [GO:0051668]; lysosome organization [GO:0007040]; memory [GO:0007613]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; neuromuscular junction development [GO:0007528]; phagosome-lysosome fusion involved in apoptotic cell clearance [GO:0090389]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; regulation of store-operated calcium entry [GO:2001256]; skeletal muscle fiber development [GO:0048741]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]; walking behavior [GO:0090659],axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; lysosomal membrane [GO:0005765]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; synapse [GO:0045202],protein kinase binding [GO:0019901],GO:0005730; GO:0005783; GO:0005829; GO:0005886; GO:0006886; GO:0006913; GO:0007018; GO:0007040; GO:0012501; GO:0023052; GO:0030163; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0050877; GO:0061024,nucleolus; endoplasmic reticulum; cytosol; plasma membrane; intracellular protein transport; nucleocytoplasmic transport; microtubule-based movement; lysosome organization; programmed cell death; signaling; protein catabolic process; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; nervous system process; membrane organization
OG_03863,0.2911544998223825,FUN_015366-T1,Peve_00000210,Pocillopora_meandrina_HIv1___RNAseq.g21696.t1,three_way,87.96916666666667,FUN_015366-T1,Q9D8V0,SPP_MOUSE,,Signal peptide peptidase (EC 3.4.23.-) (Minor histocompatibility antigen H13) (Presenilin-like protein 3) (Signal peptide peptidase-like 1),Mus musculus (Mouse),64.6,350.0,7.2e-124,445.3,sp|Q9D8V0|SPP_MOUSE Signal peptide peptidase OS=Mus musculus OX=10090 GN=Hm13 PE=1 SV=1,GO:0001701; GO:0005783; GO:0005789; GO:0005791; GO:0005886; GO:0008233; GO:0009986; GO:0031625; GO:0033619; GO:0036513; GO:0042500; GO:0042803; GO:0098553; GO:0098554; GO:1904211,"in utero embryonic development [GO:0001701]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]",cell surface [GO:0009986]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lumenal side of endoplasmic reticulum membrane [GO:0098553]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791],"aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]",GO:0003824; GO:0005783; GO:0005886; GO:0016787; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; endoplasmic reticulum; plasma membrane; hydrolase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_00853,0.2904033492010607,FUN_004115-T1,Peve_00008071,Pocillopora_meandrina_HIv1___RNAseq.g11666.t1,three_way,69.32233333333333,FUN_004115-T1,O94632,EGT1_SCHPO,,Ergothioneine biosynthesis protein 1 (Meiotically up-regulated gene 158 protein) [Includes: L-histidine N(alpha)-methyltransferase (EC 2.1.1.44); Hercynylcysteine S-oxide synthase (EC 1.21.3.10)],Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast),28.3,184.0,1.9e-09,66.2,sp|O94632|EGT1_SCHPO Ergothioneine biosynthesis protein 1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=egt1 PE=1 SV=4,GO:0004497; GO:0005509; GO:0005634; GO:0005829; GO:0032259; GO:0051321; GO:0052699; GO:0052706; GO:0061686; GO:1903257,ergothioneine biosynthetic process [GO:0052699]; meiotic cell cycle [GO:0051321]; methylation [GO:0032259]; selenoneine biosynthetic process [GO:1903257],cytosol [GO:0005829]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; hercynylcysteine sulfoxide synthase activity [GO:0061686]; L-histidine N(alpha)-methyltransferase activity [GO:0052706]; monooxygenase activity [GO:0004497],GO:0003824; GO:0005634; GO:0005829; GO:0006575; GO:0006790; GO:0016491; GO:0016740; GO:0022414; GO:0043226,catalytic activity; nucleus; cytosol; modified amino acid metabolic process; sulfur compound metabolic process; oxidoreductase activity; transferase activity; reproductive process; organelle
OG_01792,0.290264959239904,FUN_007172-T1,Peve_00019754,Pocillopora_meandrina_HIv1___RNAseq.g19765.t1b,three_way,69.35266666666666,FUN_007172-T1,O16025,AOSL_PLEHO,,Allene oxide synthase-lipoxygenase protein [Includes: Allene oxide synthase (AOS) (EC 4.2.1.-) (Hydroperoxidehydrase); Arachidonate 8-lipoxygenase (EC 1.13.11.40)],Plexaura homomalla (Black sea rod),43.9,1072.0,5.8e-264,912.1,sp|O16025|AOSL_PLEHO Allene oxide synthase-lipoxygenase protein OS=Plexaura homomalla OX=47982 PE=1 SV=1,GO:0005506; GO:0005737; GO:0006633; GO:0009978; GO:0016020; GO:0019369; GO:0020037; GO:0031408; GO:0034440; GO:0047677,arachidonate metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; lipid oxidation [GO:0034440]; oxylipin biosynthetic process [GO:0031408],cytoplasm [GO:0005737]; membrane [GO:0016020],allene oxide synthase activity [GO:0009978]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; heme binding [GO:0020037]; iron ion binding [GO:0005506],GO:0003824; GO:0006629; GO:0016491; GO:0016829,catalytic activity; lipid metabolic process; oxidoreductase activity; lyase activity
OG_04624,0.2900310494281585,FUN_022332-T1,Peve_00028602,Pocillopora_meandrina_HIv1___RNAseq.g4651.t2,three_way,52.3965,FUN_022332-T1,P26008,,,,,27.8,994.0,3.3000000000000003e-81,305.1,sp|P26008|ITAV_CHICK Integrin alpha-V OS=Gallus gallus OX=9031 GN=ITGAV PE=2 SV=1,,,,,,
OG_04042,0.2898204658505038,FUN_016351-T1,Peve_00004332,Pocillopora_meandrina_HIv1___RNAseq.g9676.t1,three_way,80.54966666666667,FUN_016351-T1,Q6ZMI0,PPR21_HUMAN,,Protein phosphatase 1 regulatory subunit 21 (Coiled-coil domain-containing protein 128) (Ferry endosomal RAB5 effector complex subunit 2) (Fy-2) (KLRAQ motif-containing protein 1),Homo sapiens (Human),40.8,787.0,5.8e-136,486.5,sp|Q6ZMI0|PPR21_HUMAN Protein phosphatase 1 regulatory subunit 21 OS=Homo sapiens OX=9606 GN=PPP1R21 PE=1 SV=1,GO:0003723; GO:0005769; GO:0016020,,early endosome [GO:0005769]; membrane [GO:0016020],RNA binding [GO:0003723],GO:0003723; GO:0005768; GO:0031410; GO:0043226,RNA binding; endosome; cytoplasmic vesicle; organelle
OG_00135,0.289106345496129,FUN_000569-T1,Peve_00034755,Pocillopora_meandrina_HIv1___RNAseq.g2452.t1,three_way,73.191,FUN_000569-T1,Q9CXF4,,,,,39.4,632.0,6.3e-121,436.4,sp|Q9CXF4|TBC15_MOUSE TBC1 domain family member 15 OS=Mus musculus OX=10090 GN=Tbc1d15 PE=1 SV=1,,,,,,
OG_10078,0.2890398509174776,FUN_043387-T1,Peve_00024251,Pocillopora_meandrina_HIv1___RNAseq.g8999.t1,three_way,69.81466666666667,FUN_043387-T1,P02468,LAMC1_MOUSE,,Laminin subunit gamma-1 (Laminin B2 chain) (Laminin-1 subunit gamma) (Laminin-10 subunit gamma) (Laminin-11 subunit gamma) (Laminin-2 subunit gamma) (Laminin-3 subunit gamma) (Laminin-4 subunit gamma) (Laminin-6 subunit gamma) (Laminin-7 subunit gamma) (Laminin-8 subunit gamma) (Laminin-9 subunit gamma) (S-laminin subunit gamma) (S-LAM gamma),Mus musculus (Mouse),41.9,1369.0,3.9000000000000004e-227,790.4,sp|P02468|LAMC1_MOUSE Laminin subunit gamma-1 OS=Mus musculus OX=10090 GN=Lamc1 PE=1 SV=2,GO:0005201; GO:0005576; GO:0005604; GO:0006325; GO:0007155; GO:0010467; GO:0016477; GO:0022617; GO:0031069; GO:0031175; GO:0031581; GO:0031594; GO:0035315; GO:0043083; GO:0043208; GO:0043259; GO:0045785; GO:0048729; GO:0051149; GO:0062023; GO:0065003; GO:0071335; GO:0098637; GO:0110011; GO:2001046,cell adhesion [GO:0007155]; cell migration [GO:0016477]; chromatin organization [GO:0006325]; extracellular matrix disassembly [GO:0022617]; gene expression [GO:0010467]; hair cell differentiation [GO:0035315]; hair follicle cell proliferation [GO:0071335]; hair follicle morphogenesis [GO:0031069]; hemidesmosome assembly [GO:0031581]; neuron projection development [GO:0031175]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; protein-containing complex assembly [GO:0065003]; regulation of basement membrane organization [GO:0110011]; tissue morphogenesis [GO:0048729],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; laminin-10 complex [GO:0043259]; neuromuscular junction [GO:0031594]; protein complex involved in cell-matrix adhesion [GO:0098637]; synaptic cleft [GO:0043083],extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208],GO:0005198; GO:0005576; GO:0006325; GO:0007155; GO:0008289; GO:0030154; GO:0030198; GO:0030312; GO:0031012; GO:0034330; GO:0048870; GO:0065003,structural molecule activity; extracellular region; chromatin organization; cell adhesion; lipid binding; cell differentiation; extracellular matrix organization; external encapsulating structure; extracellular matrix; cell junction organization; cell motility; protein-containing complex assembly
OG_08406,0.2890364558518239,FUN_037057-T1,Peve_00018391,Pocillopora_meandrina_HIv1___RNAseq.g26784.t1,three_way,86.48433333333334,FUN_037057-T1,P43332,SNRPA_DROME,,U1 small nuclear ribonucleoprotein A (U1 snRNP A) (U1-A) (U1A) (Sex determination protein snf),Drosophila melanogaster (Fruit fly),70.9,234.0,2.3999999999999996e-69,263.5,sp|P43332|SNRPA_DROME U1 small nuclear ribonucleoprotein A OS=Drosophila melanogaster OX=7227 GN=snf PE=1 SV=1,GO:0000381; GO:0000398; GO:0003729; GO:0005634; GO:0005681; GO:0005685; GO:0005686; GO:0007539; GO:0008266; GO:0008380; GO:0019099; GO:0030532; GO:0030619; GO:0030620; GO:0032991; GO:0035614; GO:0042802; GO:0048477; GO:0071011; GO:0071013; GO:0097158; GO:1990904,"female germ-line sex determination [GO:0019099]; mRNA splicing, via spliceosome [GO:0000398]; oogenesis [GO:0048477]; primary sex determination, soma [GO:0007539]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]",catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686],identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; poly(U) RNA binding [GO:0008266]; pre-mRNA intronic pyrimidine-rich binding [GO:0097158]; snRNA stem-loop binding [GO:0035614]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620],GO:0003723; GO:0005634; GO:0016071; GO:0022414; GO:0043226; GO:0048856,RNA binding; nucleus; mRNA metabolic process; reproductive process; organelle; anatomical structure development
OG_09797,0.2889254009554982,FUN_042605-T1,Peve_00034914,Pocillopora_meandrina_HIv1___RNAseq.g16849.t1a,three_way,81.68166666666667,FUN_042605-T1,Q9QUM7,,,,,46.1,798.0,1.1e-204,714.9,sp|Q9QUM7|MSH5_MOUSE MutS protein homolog 5 OS=Mus musculus OX=10090 GN=Msh5 PE=1 SV=1,,,,,,
OG_07628,0.288877492955816,FUN_034376-T1,Peve_00027168,Pocillopora_meandrina_HIv1___RNAseq.g26154.t1,three_way,68.84483333333333,FUN_034376-T1,E7FAG6,AMR1A_DANRE,,Activating molecule in BECN1-regulated autophagy protein 1A,Danio rerio (Zebrafish) (Brachydanio rerio),26.3,954.0,1.9e-61,238.8,sp|E7FAG6|AMR1A_DANRE Activating molecule in BECN1-regulated autophagy protein 1A OS=Danio rerio OX=7955 GN=ambra1a PE=2 SV=2,GO:0000045; GO:0000209; GO:0000423; GO:0005634; GO:0005739; GO:0005776; GO:0005783; GO:0005829; GO:0005856; GO:0005925; GO:0006914; GO:0007626; GO:0008406; GO:0031410; GO:0043009; GO:0043231; GO:0045591; GO:0048741; GO:0072542; GO:0080008; GO:1901526; GO:1904544; GO:1990756; GO:2000045,autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; chordate embryonic development [GO:0043009]; gonad development [GO:0008406]; locomotory behavior [GO:0007626]; mitophagy [GO:0000423]; positive regulation of free ubiquitin chain polymerization [GO:1904544]; positive regulation of mitophagy [GO:1901526]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein polyubiquitination [GO:0000209]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; skeletal muscle fiber development [GO:0048741],autophagosome [GO:0005776]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634],protein phosphatase activator activity [GO:0072542]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005634; GO:0005739; GO:0005773; GO:0005783; GO:0005829; GO:0005856; GO:0006914; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0060090; GO:0098772,nucleus; mitochondrion; vacuole; endoplasmic reticulum; cytosol; cytoskeleton; autophagy; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity
OG_10208,0.2888379294863438,FUN_043643-T1,Peve_00004207,Pocillopora_meandrina_HIv1___RNAseq.g7409.t1,three_way,56.01,,,,,,,,,,,,,,,,,
OG_00691,0.2884244480942493,FUN_002378-T1,Peve_00034013,Pocillopora_meandrina_HIv1___RNAseq.g21.t1,three_way,75.79133333333333,FUN_002378-T1,Q8TCT0,CERK1_HUMAN,,Ceramide kinase (hCERK) (EC 2.7.1.138) (Acylsphingosine kinase) (Lipid kinase 4) (LK4),Homo sapiens (Human),45.1,457.0,4.400000000000001e-111,403.3,sp|Q8TCT0|CERK1_HUMAN Ceramide kinase OS=Homo sapiens OX=9606 GN=CERK PE=1 SV=1,GO:0000287; GO:0001729; GO:0005524; GO:0005737; GO:0005886; GO:0006672; GO:0006688; GO:0016020,ceramide metabolic process [GO:0006672]; glycosphingolipid biosynthetic process [GO:0006688],cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; magnesium ion binding [GO:0000287],GO:0003824; GO:0005886; GO:0006629; GO:0016740; GO:1901135,catalytic activity; plasma membrane; lipid metabolic process; transferase activity; carbohydrate derivative metabolic process
OG_04878,0.2870644677374388,FUN_022909-T1,Peve_00001833,Pocillopora_meandrina_HIv1___RNAseq.g3706.t1,three_way,71.17616666666667,FUN_022909-T1,A2RSY1,KANL3_MOUSE,,KAT8 regulatory NSL complex subunit 3 (NSL complex protein NSL3) (Non-specific lethal 3 homolog),Mus musculus (Mouse),49.6,516.0,4.3000000000000004e-134,480.7,sp|A2RSY1|KANL3_MOUSE KAT8 regulatory NSL complex subunit 3 OS=Mus musculus OX=10090 GN=Kansl3 PE=1 SV=1,GO:0000123; GO:0000922; GO:0005654; GO:0005739; GO:0006325; GO:0044545; GO:0045893; GO:0051011; GO:0090307; GO:1903108,chromatin organization [GO:0006325]; mitotic spindle assembly [GO:0090307]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of mitochondrial transcription [GO:1903108],histone acetyltransferase complex [GO:0000123]; mitochondrion [GO:0005739]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922],microtubule minus-end binding [GO:0051011],GO:0005654; GO:0005739; GO:0006325; GO:0006355; GO:0007010; GO:0008092; GO:0043226,nucleoplasm; mitochondrion; chromatin organization; regulation of DNA-templated transcription; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_07254,0.286650125683373,FUN_033020-T1,Peve_00020848,Pocillopora_meandrina_HIv1___RNAseq.g24458.t1,three_way,61.12266666666667,FUN_033020-T1,Q9Y6N7,ROBO1_HUMAN,,Roundabout homolog 1 (Deleted in U twenty twenty) (H-Robo-1),Homo sapiens (Human),32.5,271.0,1.0999999999999998e-24,116.7,sp|Q9Y6N7|ROBO1_HUMAN Roundabout homolog 1 OS=Homo sapiens OX=9606 GN=ROBO1 PE=1 SV=1,GO:0002042; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0007155; GO:0007156; GO:0007399; GO:0008046; GO:0009986; GO:0010628; GO:0010629; GO:0016199; GO:0021836; GO:0030275; GO:0030336; GO:0030424; GO:0030949; GO:0033116; GO:0033600; GO:0035025; GO:0035385; GO:0035904; GO:0042802; GO:0043410; GO:0045747; GO:0050772; GO:0050925; GO:0060412; GO:0070100; GO:1900748,aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon midline choice point recognition [GO:0016199]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; nervous system development [GO:0007399]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412],axon [GO:0030424]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; plasma membrane [GO:0005886],axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275],GO:0005829; GO:0005886; GO:0005929; GO:0007155; GO:0043226; GO:0048856; GO:0048870; GO:0060089,cytosol; plasma membrane; cilium; cell adhesion; organelle; anatomical structure development; cell motility; molecular transducer activity
OG_08386,0.2861567070822807,FUN_036993-T1,Peve_00002136,Pocillopora_meandrina_HIv1___RNAseq.g26710.t1,three_way,55.684333333333335,FUN_036993-T1,Q6L8S8,,,,,31.9,990.0,7.700000000000001e-126,453.4,"sp|Q6L8S8|B4GN3_MOUSE Beta-1,4-N-acetylgalactosaminyltransferase 3 OS=Mus musculus OX=10090 GN=B4galnt3 PE=2 SV=1",,,,,,
OG_05871,0.2860200681518123,FUN_025986-T1,Peve_00002322,Pocillopora_meandrina_HIv1___TS.g13918.t1,three_way,61.095,FUN_025986-T1,Q8K2A1,,,,,50.5,186.0,1e-43,179.1,sp|Q8K2A1|GULP1_MOUSE PTB domain-containing engulfment adapter protein 1 OS=Mus musculus OX=10090 GN=Gulp1 PE=1 SV=1,,,,,,
OG_00635,0.2858407202533448,FUN_001860-T1,Peve_00032178,Pocillopora_meandrina_HIv1___RNAseq.g2600.t1,three_way,73.505,FUN_001860-T1,Q10741,ADA10_BOVIN,,Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (Myelin-associated metalloproteinase) (CD antigen CD156c),Bos taurus (Bovine),45.6,754.0,1.3e-175,618.2,sp|Q10741|ADA10_BOVIN Disintegrin and metalloproteinase domain-containing protein 10 OS=Bos taurus OX=9913 GN=ADAM10 PE=1 SV=1,GO:0000139; GO:0001701; GO:0002315; GO:0004175; GO:0004222; GO:0005634; GO:0005737; GO:0005794; GO:0005798; GO:0005886; GO:0005912; GO:0006468; GO:0006509; GO:0007162; GO:0007219; GO:0008237; GO:0008284; GO:0008593; GO:0009986; GO:0010629; GO:0010820; GO:0014069; GO:0016485; GO:0017124; GO:0019901; GO:0030136; GO:0030307; GO:0030424; GO:0030425; GO:0034332; GO:0034612; GO:0038004; GO:0042117; GO:0042803; GO:0042987; GO:0046872; GO:0046930; GO:0046931; GO:0051089; GO:0070573; GO:0090102; GO:0097038; GO:0097060; GO:0097197; GO:0098696; GO:0098978; GO:0099173; GO:0099175; GO:0140249; GO:1901342; GO:1902945,adherens junction organization [GO:0034332]; amyloid precursor protein catabolic process [GO:0042987]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; epidermal growth factor receptor ligand maturation [GO:0038004]; in utero embryonic development [GO:0001701]; marginal zone B cell differentiation [GO:0002315]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; negative regulation of gene expression [GO:0010629]; Notch signaling pathway [GO:0007219]; pore complex assembly [GO:0046931]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein catabolic process at postsynapse [GO:0140249]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of postsynapse organization [GO:0099175]; regulation of vasculature development [GO:1901342]; response to tumor necrosis factor [GO:0034612],adherens junction [GO:0005912]; axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; tetraspanin-enriched microdomain [GO:0097197],endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124],GO:0002376; GO:0003824; GO:0005634; GO:0005794; GO:0005886; GO:0016787; GO:0030154; GO:0030163; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0051604; GO:0065003; GO:0140096,"immune system process; catalytic activity; nucleus; Golgi apparatus; plasma membrane; hydrolase activity; cell differentiation; protein catabolic process; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; protein maturation; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_01914,0.2855253951519991,FUN_007939-T1,Peve_00040694,Pocillopora_meandrina_HIv1___RNAseq.g18118.t1,three_way,57.98416666666667,FUN_007939-T1,Q5RET9,SDE2_PONAB,,Splicing regulator SDE2 (Replication stress response regulator SDE2),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),34.2,415.0,1.7e-38,161.8,sp|Q5RET9|SDE2_PONAB Splicing regulator SDE2 OS=Pongo abelii OX=9601 GN=SDE2 PE=2 SV=1,GO:0000479; GO:0003677; GO:0005634; GO:0005737; GO:0006260; GO:0030515; GO:0045292; GO:0051301,"cell division [GO:0051301]; DNA replication [GO:0006260]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; mRNA cis splicing, via spliceosome [GO:0045292]",cytoplasm [GO:0005737]; nucleus [GO:0005634],DNA binding [GO:0003677]; snoRNA binding [GO:0030515],GO:0003677; GO:0003723; GO:0005634; GO:0006260; GO:0016071; GO:0043226,DNA binding; RNA binding; nucleus; DNA replication; mRNA metabolic process; organelle
OG_01611,0.2848342940921384,FUN_006656-T1,Peve_00029042,Pocillopora_meandrina_HIv1___RNAseq.3492_t,three_way,56.7115,FUN_006656-T1,Q9HC56,,,,,32.8,704.0,2.2e-87,325.5,sp|Q9HC56|PCDH9_HUMAN Protocadherin-9 OS=Homo sapiens OX=9606 GN=PCDH9 PE=1 SV=2,,,,,,
OG_07344,0.2848237670744921,FUN_033751-T1,Peve_00004933,Pocillopora_meandrina_HIv1___TS.g8542.t1,three_way,79.90966666666667,FUN_033751-T1,O95461,,,,,60.2,689.0,6.4e-254,878.2,sp|O95461|LARG1_HUMAN Xylosyl- and glucuronyltransferase LARGE1 OS=Homo sapiens OX=9606 GN=LARGE1 PE=1 SV=1,,,,,,
OG_00338,0.2839862681853666,FUN_001160-T1,Peve_00043472,Pocillopora_meandrina_HIv1___RNAseq.g29219.t1,three_way,80.853,FUN_001160-T1,P50416,CPT1A_HUMAN,,"Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) (Succinyltransferase CPT1A) (EC 2.3.1.-)",Homo sapiens (Human),40.4,798.0,1.7e-154,548.1,"sp|P50416|CPT1A_HUMAN Carnitine O-palmitoyltransferase 1, liver isoform OS=Homo sapiens OX=9606 GN=CPT1A PE=1 SV=2",GO:0001666; GO:0001676; GO:0004095; GO:0005739; GO:0005741; GO:0006006; GO:0006631; GO:0006635; GO:0006641; GO:0006853; GO:0007584; GO:0009410; GO:0009437; GO:0010883; GO:0016020; GO:0030674; GO:0030855; GO:0032000; GO:0042755; GO:0042802; GO:0043279; GO:0045089; GO:0045471; GO:0046222; GO:0050796; GO:0071398; GO:0097421; GO:1904772,aflatoxin metabolic process [GO:0046222]; carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of innate immune response [GO:0045089]; regulation of insulin secretion [GO:0050796]; regulation of lipid storage [GO:0010883]; response to alkaloid [GO:0043279]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; response to tetrachloromethane [GO:1904772]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641],membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674],GO:0003824; GO:0005739; GO:0005975; GO:0006575; GO:0006629; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0055085; GO:0060090,catalytic activity; mitochondrion; carbohydrate metabolic process; modified amino acid metabolic process; lipid metabolic process; transferase activity; cell differentiation; organelle; anatomical structure development; transmembrane transport; molecular adaptor activity
OG_04715,0.2836581149609118,FUN_022527-T1,Peve_00020803,Pocillopora_meandrina_HIv1___RNAseq.g4524.t2,three_way,62.5415,FUN_022527-T1,Q9NYL2,M3K20_HUMAN,,Mitogen-activated protein kinase kinase kinase 20 (EC 2.7.11.25) (Human cervical cancer suppressor gene 4 protein) (HCCS-4) (Leucine zipper- and sterile alpha motif-containing kinase) (MLK-like mitogen-activated protein triple kinase) (Mitogen-activated protein kinase kinase kinase MLT) (Mixed lineage kinase 7) (Mixed lineage kinase-related kinase) (MLK-related kinase) (MRK) (Sterile alpha motif- and leucine zipper-containing kinase AZK),Homo sapiens (Human),50.5,533.0,3.2e-135,484.2,sp|Q9NYL2|M3K20_HUMAN Mitogen-activated protein kinase kinase kinase 20 OS=Homo sapiens OX=9606 GN=MAP3K20 PE=1 SV=3,GO:0000077; GO:0000165; GO:0000287; GO:0003723; GO:0004674; GO:0004706; GO:0004709; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0006954; GO:0007010; GO:0007059; GO:0007254; GO:0008219; GO:0019887; GO:0030071; GO:0030154; GO:0030295; GO:0031098; GO:0038066; GO:0042733; GO:0043022; GO:0043065; GO:0043068; GO:0046777; GO:0051403; GO:0060173; GO:0070181; GO:0070269; GO:0070303; GO:0071480; GO:0071493; GO:0106310; GO:0140469; GO:0170011; GO:1902010; GO:1904291,cell death [GO:0008219]; cell differentiation [GO:0030154]; cellular response to gamma radiation [GO:0071480]; cellular response to UV-B [GO:0071493]; chromosome segregation [GO:0007059]; cytoskeleton organization [GO:0007010]; DNA damage checkpoint signaling [GO:0000077]; embryonic digit morphogenesis [GO:0042733]; GCN2-mediated signaling [GO:0140469]; inflammatory response [GO:0006954]; JNK cascade [GO:0007254]; limb development [GO:0060173]; MAPK cascade [GO:0000165]; negative regulation of stress-activated protein kinase signaling cascade [GO:0070303]; negative regulation of translation in response to endoplasmic reticulum stress [GO:1902010]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of mitotic DNA damage checkpoint [GO:1904291]; positive regulation of programmed cell death [GO:0043068]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; pyroptotic inflammatory response [GO:0070269]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; stress-activated MAPK cascade [GO:0051403]; stress-activated protein kinase signaling cascade [GO:0031098],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activator activity [GO:0030295]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; stalled ribosome sensor activity [GO:0170011],GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0006954; GO:0007010; GO:0007059; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0098772; GO:0140096; GO:0140299,"RNA binding; catalytic activity; nucleus; cytosol; inflammatory response; cytoskeleton organization; chromosome segregation; transferase activity; cell differentiation; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein; molecular sensor activity"
OG_00184,0.2828729518588484,FUN_000879-T1,Peve_00039669,Pocillopora_meandrina_HIv1___RNAseq.g29430.t1,three_way,82.648,FUN_000879-T1,Q5XK92,,,,,39.4,668.0,1.9000000000000002e-117,425.2,sp|Q5XK92|CIP2A_XENLA Protein CIP2A homolog L OS=Xenopus laevis OX=8355 GN=cip2a.L PE=2 SV=1,,,,,,
OG_09940,0.2828258004998704,FUN_043101-T1,Peve_00026301,Pocillopora_meandrina_HIv1___TS.g740.t1,three_way,67.05266666666667,FUN_043101-T1,Q8R4K8,PAPP1_MOUSE,,Pappalysin-1 (EC 3.4.24.79) (Insulin-like growth factor-dependent IGF-binding protein 4 protease) (IGF-dependent IGFBP-4 protease) (IGFBP-4ase) (Pregnancy-associated plasma protein A) (PAPP-A),Mus musculus (Mouse),39.8,1552.0,3.3e-308,1059.7,sp|Q8R4K8|PAPP1_MOUSE Pappalysin-1 OS=Mus musculus OX=10090 GN=Pappa PE=2 SV=2,GO:0004175; GO:0005615; GO:0006508; GO:0008237; GO:0046872,proteolysis [GO:0006508],extracellular space [GO:0005615],endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237],GO:0003824; GO:0005615; GO:0016787; GO:0140096,"catalytic activity; extracellular space; hydrolase activity; catalytic activity, acting on a protein"
OG_08750,0.2827112413599631,FUN_038017-T1,Peve_00009818,Pocillopora_meandrina_HIv1___RNAseq.g26530.t2,three_way,84.67783333333334,FUN_038017-T1,A6NCI4,VWA3A_HUMAN,,von Willebrand factor A domain-containing protein 3A,Homo sapiens (Human),37.6,1172.0,1.8000000000000002e-227,791.2,sp|A6NCI4|VWA3A_HUMAN von Willebrand factor A domain-containing protein 3A OS=Homo sapiens OX=9606 GN=VWA3A PE=1 SV=3,GO:0005576,,extracellular region [GO:0005576],,GO:0005576,extracellular region
OG_08785,0.2823612000356431,FUN_038074-T1,Peve_00000950,Pocillopora_meandrina_HIv1___RNAseq.g801.t1,three_way,77.11666666666666,FUN_038074-T1,A7MBC2,,,,,36.1,660.0,2.4e-110,401.4,sp|A7MBC2|PDXD1_BOVIN Pyridoxal-dependent decarboxylase domain-containing protein 1 OS=Bos taurus OX=9913 GN=PDXDC1 PE=2 SV=1,,,,,,
OG_03261,0.2818732177022875,FUN_013085-T1,Peve_00027392,Pocillopora_meandrina_HIv1___RNAseq.g13092.t2,three_way,58.874,FUN_013085-T1,Q8IZH2,XRN1_HUMAN,,5'-3' exoribonuclease 1 (EC 3.1.13.-) (Strand-exchange protein 1 homolog),Homo sapiens (Human),45.9,1541.0,0.0,1238.8,sp|Q8IZH2|XRN1_HUMAN 5'-3' exoribonuclease 1 OS=Homo sapiens OX=9606 GN=XRN1 PE=1 SV=1,GO:0000932; GO:0000956; GO:0002151; GO:0003723; GO:0004534; GO:0005634; GO:0005829; GO:0005886; GO:0016020; GO:0016075; GO:0017148; GO:0030425; GO:0032211; GO:0033574; GO:0043025; GO:0051880; GO:0070034; GO:0071028; GO:0071044; GO:0071409; GO:1905795,cellular response to cycloheximide [GO:0071409]; cellular response to puromycin [GO:1905795]; histone mRNA catabolic process [GO:0071044]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; response to testosterone [GO:0033574]; rRNA catabolic process [GO:0016075],cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886],5'-3' RNA exonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0016071; GO:0016787; GO:0043226; GO:0140098,"DNA binding; RNA binding; catalytic activity; nucleus; cytosol; plasma membrane; mRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_03939,0.2812392923794778,FUN_016071-T1,Peve_00021918,Pocillopora_meandrina_HIv1___RNAseq.g21619.t1,three_way,78.3115,FUN_016071-T1,Q8JHJ2,,,,,64.9,470.0,1.8e-177,624.0,sp|Q8JHJ2|DDX55_DANRE ATP-dependent RNA helicase DDX55 OS=Danio rerio OX=7955 GN=ddx55 PE=2 SV=2,,,,,,
OG_07039,0.281176931100581,FUN_032235-T1,Peve_00043486,Pocillopora_meandrina_HIv1___RNAseq.g24841.t1,three_way,59.83833333333334,,,,,,,,,,,,,,,,,
OG_04750,0.2810298841077656,FUN_022634-T1,Peve_00012928,Pocillopora_meandrina_HIv1___RNAseq.g9361.t1,three_way,87.668,FUN_022634-T1,Q7Z4L5,TT21B_HUMAN,,Tetratricopeptide repeat protein 21B (TPR repeat protein 21B) (Intraflagellar transport 139 homolog),Homo sapiens (Human),54.7,1309.0,0.0,1412.5,sp|Q7Z4L5|TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens OX=9606 GN=TTC21B PE=1 SV=2,GO:0003682; GO:0005737; GO:0005856; GO:0005929; GO:0006357; GO:0007224; GO:0008589; GO:0010628; GO:0021591; GO:0021702; GO:0021798; GO:0030991; GO:0035721; GO:0060020; GO:0060271; GO:0061512; GO:0090263; GO:0097499; GO:0097542; GO:1903999; GO:1905799,Bergmann glial cell differentiation [GO:0060020]; cerebellar Purkinje cell differentiation [GO:0021702]; cilium assembly [GO:0060271]; forebrain dorsal/ventral pattern formation [GO:0021798]; intraciliary retrograde transport [GO:0035721]; negative regulation of eating behavior [GO:1903999]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; protein localization to cilium [GO:0061512]; protein localization to non-motile cilium [GO:0097499]; regulation of intraciliary retrograde transport [GO:1905799]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; ventricular system development [GO:0021591],ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991],chromatin binding [GO:0003682],GO:0005856; GO:0005929; GO:0006355; GO:0007018; GO:0030154; GO:0043226; GO:0044782; GO:0048856,cytoskeleton; cilium; regulation of DNA-templated transcription; microtubule-based movement; cell differentiation; organelle; cilium organization; anatomical structure development
OG_02702,0.2808597746515671,FUN_010977-T1,Peve_00013380,Pocillopora_meandrina_HIv1___RNAseq.g22016.t2,three_way,61.6055,FUN_010977-T1,Q8VCM2,NOXO1_MOUSE,,NADPH oxidase organizer 1 (Nox organizer 1) (Sorting nexin-28),Mus musculus (Mouse),34.5,110.0,2e-12,76.3,sp|Q8VCM2|NOXO1_MOUSE NADPH oxidase organizer 1 OS=Mus musculus OX=10090 GN=Noxo1 PE=1 SV=2,GO:0005886; GO:0006801; GO:0016176; GO:0019899; GO:0022617; GO:0035091; GO:0043020,extracellular matrix disassembly [GO:0022617]; superoxide metabolic process [GO:0006801],NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886],enzyme binding [GO:0019899]; phosphatidylinositol binding [GO:0035091]; superoxide-generating NADPH oxidase activator activity [GO:0016176],GO:0005886; GO:0008289; GO:0030198; GO:0098772,plasma membrane; lipid binding; extracellular matrix organization; molecular function regulator activity
OG_07684,0.2804596098773879,FUN_034803-T1,Peve_00007553,Pocillopora_meandrina_HIv1___RNAseq.g12304.t1,three_way,77.09400000000001,FUN_034803-T1,Q4R4P4,FA2H_MACFA,,Fatty acid 2-hydroxylase (EC 1.14.18.-) (Fatty acid alpha-hydroxylase),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),45.3,364.0,2.4e-84,313.9,sp|Q4R4P4|FA2H_MACFA Fatty acid 2-hydroxylase OS=Macaca fascicularis OX=9541 GN=FA2H PE=2 SV=1,GO:0005506; GO:0005789; GO:0006633; GO:0006679; GO:0006682; GO:0016020; GO:0020037; GO:0044857; GO:0046513; GO:0061436; GO:0080132; GO:0120520,ceramide biosynthetic process [GO:0046513]; establishment of skin barrier [GO:0061436]; fatty acid biosynthetic process [GO:0006633]; galactosylceramide biosynthetic process [GO:0006682]; glucosylceramide biosynthetic process [GO:0006679]; plasma membrane raft organization [GO:0044857],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],fatty acid 2-hydroxylase activity [GO:0080132]; free fatty acid 2-hydroxylase activity [GO:0120520]; heme binding [GO:0020037]; iron ion binding [GO:0005506],GO:0003824; GO:0006629; GO:0016491; GO:0048856; GO:0061024; GO:1901135,catalytic activity; lipid metabolic process; oxidoreductase activity; anatomical structure development; membrane organization; carbohydrate derivative metabolic process
OG_04746,0.2801270931038965,FUN_022627-T1,Peve_00012280,Pocillopora_meandrina_HIv1___RNAseq.g4385.t1,three_way,74.43166666666667,FUN_022627-T1,Q13485,SMAD4_HUMAN,,Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4) (SMAD family member 4) (SMAD 4) (Smad4) (hSMAD4),Homo sapiens (Human),52.7,220.0,2.4e-51,205.7,sp|Q13485|SMAD4_HUMAN Mothers against decapentaplegic homolog 4 OS=Homo sapiens OX=9606 GN=SMAD4 PE=1 SV=1,GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001222; GO:0001223; GO:0001228; GO:0001541; GO:0001649; GO:0001658; GO:0001666; GO:0001701; GO:0001702; GO:0001837; GO:0003148; GO:0003161; GO:0003190; GO:0003198; GO:0003220; GO:0003251; GO:0003360; GO:0003682; GO:0003700; GO:0005518; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005813; GO:0005829; GO:0006351; GO:0006355; GO:0006357; GO:0006366; GO:0006879; GO:0007179; GO:0007283; GO:0007338; GO:0007411; GO:0008283; GO:0008285; GO:0009653; GO:0010614; GO:0010628; GO:0010631; GO:0010666; GO:0010718; GO:0014033; GO:0014898; GO:0030154; GO:0030308; GO:0030325; GO:0030509; GO:0030511; GO:0031005; GO:0032444; GO:0032525; GO:0032909; GO:0032924; GO:0033686; GO:0035556; GO:0036064; GO:0036302; GO:0042118; GO:0042177; GO:0042733; GO:0042802; GO:0042803; GO:0043199; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0046881; GO:0048382; GO:0048589; GO:0048665; GO:0048733; GO:0048859; GO:0051797; GO:0060065; GO:0060391; GO:0060395; GO:0060412; GO:0060956; GO:0061040; GO:0061629; GO:0062009; GO:0070102; GO:0070371; GO:0070373; GO:0070411; GO:0070412; GO:0071141; GO:0071144; GO:0071333; GO:0071559; GO:0071560; GO:0071773; GO:0072133; GO:0072134; GO:0072520; GO:0090090; GO:0097191; GO:1901203; GO:1902895; GO:1905305,activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac conduction system development [GO:0003161]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to BMP stimulus [GO:0071773]; cellular response to glucose stimulus [GO:0071333]; cellular response to transforming growth factor beta stimulus [GO:0071560]; developmental growth [GO:0048589]; DNA-templated transcription [GO:0006351]; embryonic digit morphogenesis [GO:0042733]; endocardial cell differentiation [GO:0060956]; endothelial cell activation [GO:0042118]; epithelial cell migration [GO:0010631]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; ERK1 and ERK2 cascade [GO:0070371]; extrinsic apoptotic signaling pathway [GO:0097191]; female gonad morphogenesis [GO:0061040]; formation of anatomical boundary [GO:0048859]; gastrulation with mouth forming second [GO:0001702]; in utero embryonic development [GO:0001701]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular iron ion homeostasis [GO:0006879]; intracellular signal transduction [GO:0035556]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; mesendoderm development [GO:0048382]; metanephric mesenchyme morphogenesis [GO:0072133]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac myofibril assembly [GO:1905305]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural crest cell differentiation [GO:0014033]; neuron fate specification [GO:0048665]; osteoblast differentiation [GO:0001649]; outflow tract septum morphogenesis [GO:0003148]; ovarian follicle development [GO:0001541]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell proliferation involved in heart valve morphogenesis [GO:0003251]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of gene expression [GO:0010628]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of DNA-templated transcription [GO:0006355]; regulation of hair follicle development [GO:0051797]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; response to transforming growth factor beta [GO:0071559]; sebaceous gland development [GO:0048733]; secondary palate development [GO:0062009]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; SMAD protein signal transduction [GO:0060395]; somite rostral/caudal axis specification [GO:0032525]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412],activin responsive factor complex [GO:0032444]; centrosome [GO:0005813]; chromatin [GO:0000785]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667],"chromatin binding [GO:0003682]; collagen binding [GO:0005518]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; filamin binding [GO:0031005]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sulfate binding [GO:0043199]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222]",GO:0003012; GO:0003677; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006351; GO:0006355; GO:0008092; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,muscle system process; DNA binding; nucleus; nucleoplasm; microtubule organizing center; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; cytoskeletal protein binding; reproductive process; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_01399,0.2798447721032288,FUN_005387-T1,Peve_00044223,Pocillopora_meandrina_HIv1___RNAseq.g6614.t1,three_way,86.572,FUN_005387-T1,Q32LQ4,,,,,68.3,262.0,1.9e-105,384.0,sp|Q32LQ4|BHMT1_DANRE Betaine--homocysteine S-methyltransferase 1 OS=Danio rerio OX=7955 GN=bhmt PE=2 SV=1,,,,,,
OG_09280,0.2797049276574987,FUN_040095-T1,Peve_00037198,Pocillopora_meandrina_HIv1___RNAseq.g7609.t1,three_way,67.75166666666667,,,,,,,,,,,,,,,,,
OG_00802,0.279626321839954,FUN_004000-T1,Peve_00034331,Pocillopora_meandrina_HIv1___RNAseq.g11698.t1,three_way,63.14333333333333,FUN_004000-T1,Q8CJ12,AGRG2_MOUSE,,"Adhesion G-protein coupled receptor G2 (G-protein coupled receptor 64) (Mouse epididymis-specific protein 6) (Me6) [Cleaved into: Adhesion G-protein coupled receptor G2, N-terminal fragment (ADGRG2 N-terminal fragment); Adhesion G-protein coupled receptor G2, C-terminal fragment (ADGRG2 C-terminal fragment)]",Mus musculus (Mouse),34.0,379.0,1.9e-50,203.4,sp|Q8CJ12|AGRG2_MOUSE Adhesion G-protein coupled receptor G2 OS=Mus musculus OX=10090 GN=Adgrg2 PE=1 SV=1,GO:0004930; GO:0005829; GO:0007166; GO:0007189; GO:0007286; GO:0016324,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; spermatid development [GO:0007286],apical plasma membrane [GO:0016324]; cytosol [GO:0005829],G protein-coupled receptor activity [GO:0004930],GO:0005829; GO:0022414; GO:0048856; GO:0060089,cytosol; reproductive process; anatomical structure development; molecular transducer activity
OG_00952,0.2791616972669152,FUN_004312-T1,Peve_00033934,Pocillopora_meandrina_HIv1___RNAseq.g16986.t1,three_way,70.072,FUN_004312-T1,Q98864,,,,,42.5,1133.0,1.3999999999999999e-244,847.8,sp|Q98864|PTC1_DANRE Protein patched homolog 1 OS=Danio rerio OX=7955 GN=ptch1 PE=2 SV=1,,,,,,
OG_04160,0.2791551312676067,FUN_016638-T1,Peve_00026352,Pocillopora_meandrina_HIv1___RNAseq.g102.t1,three_way,61.59666666666666,FUN_016638-T1,Q62136,,,,,27.0,1183.0,6.6999999999999995e-90,333.6,sp|Q62136|PTN21_MOUSE Tyrosine-protein phosphatase non-receptor type 21 OS=Mus musculus OX=10090 GN=Ptpn21 PE=1 SV=1,,,,,,
OG_09229,0.2790178844891351,FUN_039966-T1,Peve_00039035,Pocillopora_meandrina_HIv1___RNAseq.g7517.t1a,three_way,70.402,,,,,,,,,,,,,,,,,
OG_08707,0.2787647872549412,FUN_037957-T1,Peve_00040730,Pocillopora_meandrina_HIv1___TS.g19259.t1,three_way,88.39133333333334,FUN_037957-T1,Q96HU1,SGSM3_HUMAN,,Small G protein signaling modulator 3 (Merlin-associated protein) (RUN and TBC1 domain-containing protein 3) (Rab-GTPase-activating protein-like protein) (RabGAPLP),Homo sapiens (Human),61.7,798.0,1.2e-288,993.8,sp|Q96HU1|SGSM3_HUMAN Small G protein signaling modulator 3 OS=Homo sapiens OX=9606 GN=SGSM3 PE=1 SV=1,GO:0005096; GO:0005829; GO:0005921; GO:0031267; GO:0032483; GO:0032486; GO:0043547; GO:0045732; GO:0048227; GO:0051726,plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein catabolic process [GO:0045732]; Rap protein signal transduction [GO:0032486]; regulation of cell cycle [GO:0051726]; regulation of Rab protein signal transduction [GO:0032483],cytosol [GO:0005829]; gap junction [GO:0005921],GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],GO:0005829; GO:0016192; GO:0098772,cytosol; vesicle-mediated transport; molecular function regulator activity
OG_00007,0.2785163224970963,FUN_000194-T1,Peve_00038470,Pocillopora_meandrina_HIv1___RNAseq.g28898.t1,three_way,77.11833333333334,FUN_000194-T1,P70182,,,,,60.2,447.0,3.4e-147,523.5,sp|P70182|PI51A_MOUSE Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha OS=Mus musculus OX=10090 GN=Pip5k1a PE=1 SV=2,,,,,,
OG_03269,0.278476727200707,FUN_013138-T1,Peve_00042391,Pocillopora_meandrina_HIv1___TS.g15900.t1,three_way,81.306,FUN_013138-T1,Q7RTY7,OVCH1_HUMAN,,Ovochymase-1 (EC 3.4.21.-),Homo sapiens (Human),39.4,251.0,5.999999999999999e-44,179.5,sp|Q7RTY7|OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens OX=9606 GN=OVCH1 PE=1 SV=3,GO:0004252; GO:0005576; GO:0006508; GO:0046872,proteolysis [GO:0006508],extracellular region [GO:0005576],metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0016787; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; catalytic activity, acting on a protein"
OG_06485,0.2781700289108403,FUN_029259-T1,Peve_00024365,Pocillopora_meandrina_HIv1___RNAseq.g15031.t1b,three_way,71.01783333333333,FUN_029259-T1,Q6DN90,IQEC1_HUMAN,,IQ motif and SEC7 domain-containing protein 1 (ADP-ribosylation factors guanine nucleotide-exchange protein 100) (ADP-ribosylation factors guanine nucleotide-exchange protein 2) (Brefeldin-resistant Arf-GEF 2 protein) (BRAG2),Homo sapiens (Human),42.1,447.0,1.1e-74,283.1,sp|Q6DN90|IQEC1_HUMAN IQ motif and SEC7 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=IQSEC1 PE=1 SV=1,GO:0005085; GO:0005654; GO:0005813; GO:0005829; GO:0008021; GO:0008289; GO:0014069; GO:0016020; GO:0030036; GO:0032012; GO:0043231; GO:0051549; GO:0060996; GO:0120183,actin cytoskeleton organization [GO:0030036]; dendritic spine development [GO:0060996]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of keratinocyte migration [GO:0051549]; regulation of ARF protein signal transduction [GO:0032012],centrosome [GO:0005813]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021],guanyl-nucleotide exchange factor activity [GO:0005085]; lipid binding [GO:0008289],GO:0005654; GO:0005815; GO:0005829; GO:0007010; GO:0008289; GO:0031410; GO:0043226; GO:0048856; GO:0098772,nucleoplasm; microtubule organizing center; cytosol; cytoskeleton organization; lipid binding; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity
OG_03039,0.2778492013274173,FUN_012278-T1,Peve_00010528,Pocillopora_meandrina_HIv1___RNAseq.g23570.t1,three_way,80.52133333333333,FUN_012278-T1,Q9D5W4,,,,,40.4,708.0,7.8e-127,456.1,sp|Q9D5W4|CCD81_MOUSE Coiled-coil domain-containing protein 81 OS=Mus musculus OX=10090 GN=Ccdc81 PE=2 SV=1,,,,,,
OG_02112,0.2777807862796604,FUN_008397-T1,Peve_00043603,Pocillopora_meandrina_HIv1___RNAseq.g6179.t1,three_way,31.29733333333333,FUN_008397-T1,Q0P5F3,LIN7C_BOVIN,,Protein lin-7 homolog C (Lin-7C),Bos taurus (Bovine),35.4,99.0,4.4e-07,60.5,sp|Q0P5F3|LIN7C_BOVIN Protein lin-7 homolog C OS=Bos taurus OX=9913 GN=LIN7C PE=2 SV=1,GO:0005911; GO:0005923; GO:0006887; GO:0007269; GO:0008582; GO:0015031; GO:0016323; GO:0030674; GO:0043005; GO:0045202; GO:0048489; GO:0097025; GO:0098793; GO:0098839,exocytosis [GO:0006887]; neurotransmitter secretion [GO:0007269]; protein transport [GO:0015031]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; synaptic vesicle transport [GO:0048489],basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; MPP7-DLG1-LIN7 complex [GO:0097025]; neuron projection [GO:0043005]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202],protein-macromolecule adaptor activity [GO:0030674],GO:0016192; GO:0060090,vesicle-mediated transport; molecular adaptor activity
OG_08588,0.2774854918878685,FUN_037697-T1,Peve_00044127,Pocillopora_meandrina_HIv1___RNAseq.g1357.t1,three_way,66.68333333333334,FUN_037697-T1,Q6NZQ2,DDX31_MOUSE,,ATP-dependent DNA helicase DDX31 (EC 5.6.2.-) (DEAD box protein 31) (Probable ATP-dependent RNA helicase DDX31) (EC 3.6.4.13),Mus musculus (Mouse),46.4,686.0,1.1999999999999999e-148,528.5,sp|Q6NZQ2|DDX31_MOUSE ATP-dependent DNA helicase DDX31 OS=Mus musculus OX=10090 GN=Ddx31 PE=2 SV=2,GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0005794; GO:0016887; GO:0042254,ribosome biogenesis [GO:0042254],Golgi apparatus [GO:0005794]; nucleolus [GO:0005730],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005730; GO:0005794; GO:0016787; GO:0016853; GO:0042254; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleolus; Golgi apparatus; hydrolase activity; isomerase activity; ribosome biogenesis; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_03716,0.2773416815659659,FUN_014991-T1,Peve_00032857,Pocillopora_meandrina_HIv1___RNAseq.g21154.t2,three_way,83.89333333333333,FUN_014991-T1,Q9BUZ4,TRAF4_HUMAN,,TNF receptor-associated factor 4 (EC 2.3.2.27) (Cysteine-rich domain associated with RING and Traf domains protein 1) (Metastatic lymph node gene 62 protein) (MLN 62) (RING finger protein 83),Homo sapiens (Human),30.0,621.0,3.3e-94,347.4,sp|Q9BUZ4|TRAF4_HUMAN TNF receptor-associated factor 4 OS=Homo sapiens OX=9606 GN=TRAF4 PE=1 SV=1,GO:0001650; GO:0005164; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005923; GO:0006915; GO:0007166; GO:0007585; GO:0008270; GO:0016740; GO:0019901; GO:0030323; GO:0031625; GO:0031996; GO:0035591; GO:0042802; GO:0042981; GO:0043122; GO:0043161; GO:0045087; GO:0045860; GO:0046330; GO:0048471; GO:0050699,apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; innate immune response [GO:0045087]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein kinase activity [GO:0045860]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323],bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; signaling adaptor activity [GO:0035591]; thioesterase binding [GO:0031996]; transferase activity [GO:0016740]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0012501; GO:0016740; GO:0030163; GO:0043226; GO:0048856; GO:0060090; GO:0098542,immune system process; catalytic activity; nucleus; nucleoplasm; cytosol; cytoskeleton; plasma membrane; programmed cell death; transferase activity; protein catabolic process; organelle; anatomical structure development; molecular adaptor activity; defense response to other organism
OG_01021,0.2772327028956066,FUN_004453-T1,Peve_00024317,Pocillopora_meandrina_HIv1___RNAseq.g5040.t1,three_way,69.144,FUN_004453-T1,Q5GN48,DMD_PIG,,Dystrophin,Sus scrofa (Pig),36.3,557.0,9.2e-96,352.4,sp|Q5GN48|DMD_PIG Dystrophin OS=Sus scrofa OX=9823 GN=DMD PE=1 SV=1,GO:0003779; GO:0005737; GO:0005856; GO:0007519; GO:0008270; GO:0016010; GO:0042383; GO:0045211; GO:0048666; GO:0055001; GO:0090257; GO:0099536; GO:0120025,muscle cell development [GO:0055001]; neuron development [GO:0048666]; regulation of muscle system process [GO:0090257]; skeletal muscle tissue development [GO:0007519]; synaptic signaling [GO:0099536],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; plasma membrane bounded cell projection [GO:0120025]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383],actin binding [GO:0003779]; zinc ion binding [GO:0008270],GO:0005856; GO:0005886; GO:0008092; GO:0023052; GO:0043226; GO:0048856,cytoskeleton; plasma membrane; cytoskeletal protein binding; signaling; organelle; anatomical structure development
OG_07786,0.2767725201179995,FUN_035007-T1,Peve_00024588,Pocillopora_meandrina_HIv1___RNAseq.g12133.t1,three_way,76.595,FUN_035007-T1,O60268,,,,,33.6,110.0,4.3e-10,65.5,sp|O60268|K0513_HUMAN Uncharacterized protein KIAA0513 OS=Homo sapiens OX=9606 GN=KIAA0513 PE=1 SV=1,,,,,,
OG_05506,0.2767588636044116,FUN_024587-T1,Peve_00037917,Pocillopora_meandrina_HIv1___RNAseq.2717_t,three_way,63.268,,,,,,,,,,,,,,,,,
OG_08902,0.276535847098357,FUN_038330-T1,Peve_00023108,Pocillopora_meandrina_HIv1___RNAseq.g1119.t2,three_way,80.42033333333333,FUN_038330-T1,Q9EQY0,ERN1_MOUSE,,Serine/threonine-protein kinase/endoribonuclease IRE1 (Endoplasmic reticulum-to-nucleus signaling 1) (Inositol-requiring protein 1) (Ire1-alpha) (IRE1a) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)],Mus musculus (Mouse),44.5,954.0,2.3e-213,743.8,sp|Q9EQY0|ERN1_MOUSE Serine/threonine-protein kinase/endoribonuclease IRE1 OS=Mus musculus OX=10090 GN=Ern1 PE=1 SV=1,GO:0000287; GO:0001935; GO:0004519; GO:0004521; GO:0004674; GO:0005161; GO:0005524; GO:0005637; GO:0005739; GO:0005789; GO:0006468; GO:0017148; GO:0019899; GO:0030544; GO:0030968; GO:0033120; GO:0035924; GO:0036498; GO:0042803; GO:0043507; GO:0043531; GO:0046777; GO:0051879; GO:0070054; GO:0070059; GO:0070301; GO:0071333; GO:0106310; GO:1900103; GO:1901142; GO:1904294; GO:1904707; GO:1990597; GO:1990604; GO:1990630,"cellular response to glucose stimulus [GO:0071333]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; insulin metabolic process [GO:1901142]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA splicing, via endonucleolytic cleavage and ligation [GO:0070054]; negative regulation of translation [GO:0017148]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of RNA splicing [GO:0033120]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]",AIP1-IRE1 complex [GO:1990597]; endoplasmic reticulum membrane [GO:0005789]; IRE1-RACK1-PP2A complex [GO:1990630]; IRE1-TRAF2-ASK1 complex [GO:1990604]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637],ADP binding [GO:0043531]; ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; magnesium ion binding [GO:0000287]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA endonuclease activity [GO:0004521],GO:0003824; GO:0005739; GO:0016071; GO:0016740; GO:0043226; GO:0140096; GO:0140098,"catalytic activity; mitochondrion; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on a protein; catalytic activity, acting on RNA"
OG_06571,0.2763435069124036,FUN_029484-T1,Peve_00017245,Pocillopora_meandrina_HIv1___RNAseq.g17128.t1,three_way,64.353,FUN_029484-T1,Q8NEA6,GLIS3_HUMAN,,Zinc finger protein GLIS3 (GLI-similar 3) (Zinc finger protein 515),Homo sapiens (Human),64.3,70.0,4.8e-23,110.9,sp|Q8NEA6|GLIS3_HUMAN Zinc finger protein GLIS3 OS=Homo sapiens OX=9606 GN=GLIS3 PE=1 SV=5,GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0005634; GO:0006357; GO:0006366; GO:0008270; GO:0045944,negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_01121,0.2762901185537627,FUN_004684-T1,Peve_00035122,Pocillopora_meandrina_HIv1___RNAseq.g8765.t1,three_way,65.35983333333333,FUN_004684-T1,Q07008,NOTC1_RAT,,Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)],Rattus norvegicus (Rat),42.2,628.0,7.7e-77,291.2,sp|Q07008|NOTC1_RAT Neurogenic locus notch homolog protein 1 OS=Rattus norvegicus OX=10116 GN=Notch1 PE=1 SV=3,GO:0000122; GO:0000987; GO:0001228; GO:0001554; GO:0001669; GO:0001701; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005634; GO:0005737; GO:0005783; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006366; GO:0006606; GO:0006915; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007440; GO:0007492; GO:0007507; GO:0008283; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009957; GO:0009986; GO:0010001; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042670; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050673; GO:0050678; GO:0050679; GO:0050680; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061314; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027,"animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process [GO:0006915]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cell population proliferation [GO:0008283]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epidermis development [GO:0008544]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]",acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685],"calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888]",GO:0002376; GO:0003677; GO:0005634; GO:0005783; GO:0005856; GO:0005886; GO:0006351; GO:0006355; GO:0006886; GO:0006913; GO:0006954; GO:0012501; GO:0016192; GO:0022414; GO:0030154; GO:0030163; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0050877; GO:0060089; GO:0060090; GO:0098772; GO:0140110,immune system process; DNA binding; nucleus; endoplasmic reticulum; cytoskeleton; plasma membrane; DNA-templated transcription; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; inflammatory response; programmed cell death; vesicle-mediated transport; reproductive process; cell differentiation; protein catabolic process; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; cell motility; nervous system process; molecular transducer activity; molecular adaptor activity; molecular function regulator activity; transcription regulator activity
OG_06125,0.2757631001649288,FUN_027903-T1,Peve_00020107,Pocillopora_meandrina_HIv1___RNAseq.g13881.t1,three_way,48.315666666666665,FUN_027903-T1,O75487,GPC4_HUMAN,,Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4],Homo sapiens (Human),33.5,507.0,6.5e-73,276.6,sp|O75487|GPC4_HUMAN Glypican-4 OS=Homo sapiens OX=9606 GN=GPC4 PE=1 SV=4,GO:0005634; GO:0005796; GO:0005886; GO:0009897; GO:0009966; GO:0009986; GO:0015026; GO:0016055; GO:0016477; GO:0043202; GO:0045202; GO:0070062; GO:0098696; GO:0098978; GO:0099560; GO:1905606,cell migration [GO:0016477]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of presynapse assembly [GO:1905606]; regulation of signal transduction [GO:0009966]; synaptic membrane adhesion [GO:0099560]; Wnt signaling pathway [GO:0016055],cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202],coreceptor activity [GO:0015026],GO:0005634; GO:0005886; GO:0007155; GO:0043226; GO:0048870; GO:0060089,nucleus; plasma membrane; cell adhesion; organelle; cell motility; molecular transducer activity
OG_01653,0.2757598926163061,FUN_006821-T1,Peve_00023763,Pocillopora_meandrina_HIv1___RNAseq.g20482.t1,three_way,90.73766666666668,FUN_006821-T1,Q9HD45,,,,,69.3,554.0,6.7e-206,718.4,sp|Q9HD45|TM9S3_HUMAN Transmembrane 9 superfamily member 3 OS=Homo sapiens OX=9606 GN=TM9SF3 PE=1 SV=2,,,,,,
OG_01258,0.2755279849419701,FUN_004990-T1,Peve_00015881,Pocillopora_meandrina_HIv1___RNAseq.g8685.t1,three_way,78.06383333333333,FUN_004990-T1,Q7Z2Z2,EFL1_HUMAN,,Elongation factor-like GTPase 1 (EC 3.6.5.-) (Elongation factor Tu GTP-binding domain-containing protein 1) (Elongation factor-like 1) (Protein FAM42A),Homo sapiens (Human),53.6,1185.0,0.0,1171.8,sp|Q7Z2Z2|EFL1_HUMAN Elongation factor-like GTPase 1 OS=Homo sapiens OX=9606 GN=EFL1 PE=1 SV=2,GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0042256; GO:0043022; GO:0046039; GO:1990904,cytosolic ribosome assembly [GO:0042256]; GTP metabolic process [GO:0046039],cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746],GO:0003824; GO:0003924; GO:0005829; GO:0016787; GO:0055086; GO:1901135,catalytic activity; GTPase activity; cytosol; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
